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As this newsletter goes to press, the government 
has not announced its intentions with regard to 
the future location of the Offi ce of the Minister 
for Drugs and its functions. However, the new 
programme for government, Government for 
National Recovery 2011–2016,1 contains a 
number of actions related to drugs policy. This 
article attempts to identify the implications of 
these actions should they be implemented.
Actions related to crime and justice
We will introduce roadside drug testing 
programmes to combat the problem of driving 
under the infl uence of drugs.
The development of reliable roadside testing procedure has been a challenging issue for many 
countries. At present the Garda Síochána, the Department of Transport and the Medical Bureau of 
Road Safety are collaborating in the development of a scheme to introduce US-style roadside tests 
on suspected drug drivers to accompany roadside alcohol tests.
We will ensure that violent offenders and other serious offenders serve appropriate prison sentences while 
at the same time switching away from prison sentences and towards less costly non-custodial options for 
non-violent and less serious offenders.
The fi rst Bill introduced by the new Minister for Justice and Law Reform is the Criminal Justice 
(Community Service) (Amendment) (No. 2) Bill. This Bill creates an obligation on the courts, when 
sentencing an offender, to consider imposing a community service order in circumstances where 
a sentence of imprisonment of up to 12 months is being considered. Although the Bill does not 
mention specifi c offences, many offenders whose offences are committed as a consequence of drug 
addiction receive short custodial sentences and could benefi t from the terms of this legislation.
A review will be conducted of the working of the mandatory sentencing laws in the context of an overall 
review of drugs policy.
The recent decision by the Supreme Court in DPP v Connolly raises a number of important issues in 
relation to the future application of s.15A and s.27 of the Misuse of Drugs Act 1977 (as amended).2 
These sections of the Act provide for a minimum presumptive sentence of ten years’ imprisonment 
for possession of drugs with a market value of €13,000 or more. The Supreme Court quashed a 
previous conviction under s.15A on the basis that the burden of proof required to determine the 
purity and therefore value of the drugs had not been met by the prosecution.
We will strengthen the supply reduction effort and criminal assets seizures, particularly at local level.
During the last Dáil, the Labour Party introduced the Proceeds of Crime (Amendment) Bill 2010. 
The purpose of the Bill was to reduce from seven years to two years the waiting period before the 
Criminal Assets Bureau can apply to the High Court for the disposal and forfeiture of assets frozen 
under s.3 of the Proceeds of Crime Act 1996. This Bill lapsed with the dissolution of the Dáil. The 
Labour Party’s election manifesto, however, is committed to reintroducing this Bill, and to the 
strengthening of drug supply reduction efforts and criminal assets seizure at a local level.
We will carry out a full review of the Drug Treatment Court programme to evaluate its success and 
potential in dealing with young offenders identifi ed as having serious problems with drugs.
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We will end the practice of sending children to St 
Patrick’s Institution.
The recent review of the Drug Treatment 
Court3 recommended that the programme 
be extended to offenders aged 16–18 years 
before the Children Court. The focus on 
young offenders may also be infl uenced by the 
commitment to end the practice of sending 
children to St Patrick’s Institution.
Actions related to implementation of policy
Ensure every government department, agency or 
task force responsible for implementing elements of 
the National Addiction Strategy will be required to 
account to the Minister for their budget annually 
and to demonstrate progress on achieving targets.
This measure aligns with Action 68 in the EU 
Drugs Action Plan 2009–2012, which calls on 
member states to ‘develop and apply analytical 
instruments to better assess the effectiveness 
and impact of drug policy (e.g. model 
evaluation tools, policy effectiveness indices, 
public expenditure analysis, etc.)’. 
In line with this action, the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) 
has developed a tool to assist member states in 
analysing their drug-related public expenditure. 
The EMCDDA distinguishes between two 
types of public expenditures – those explicitly 
labelled ‘drug-related’ and those which are 
not labelled as such and which are embedded 
in programmes with broader goals (e.g. the 
overall Garda Síochána budget). While labelled 
expenditures can be traced by exhaustively 
reviewing offi cial fi nancial reporting documents 
such as budgets and year-end reports, the 
EMCDDA advises that non-labelled expenditures 
have to be calculated through modelling/
estimation approaches. 
To date, Ireland has only reported on its labelled 
drug-related expenditures; it has not undertaken 
any modelling exercises to estimate the full 
amount of public expenditure on the illegal 
drugs issue.
Actions related to prevention 
and rehabilitation
Expand rehabilitation services at local level in line 
with need and subject to available resources.
Assist drug users in rehabilitation through 
participation in suitable local community 
employment schemes.
Work with local and regional drugs task forces 
to implement effective programmes aimed at 
preventing addiction in schools.
Require all local and regional drugs task forces to 
build on the success of Education Prevention Units 
in other task forces.
The four actions above are broadly in line with 
current drugs policy. 
Develop compulsory as well as voluntary 
rehabilitation programmes.
If implemented, this action would represent 
a signifi cant shift in policy. It is not clear how 
compulsory rehabilitation could be implemented 
in Ireland. The Welfare Reform Bill currently 
being debated in the UK parliament requires 
welfare claimants ‘who are dependent on or 
have a propensity to misuse any drug’ to follow 
a rehabilitation plan, and also contains powers to 
require welfare claimants to undergo drug testing. 
 Update the out-dated drugs awareness 
programmes in schools to refl ect current attitudes 
and reality of recreational drug use amongst teens.
This action appears to signal a shift away from 
the life-skills programmes in schools. There is 
evidence that these programmes are effective in 
improving decision-making skills and building 
resilience and resistance skills among young 
people. Alcohol, tobacco and cannabis are the 
main substances used by young school-going 
people. It is not yet clear how programmes 
can be developed to minimise the risks of such 
substance use among this population.
Actions related to treatment and 
harm reduction
Target resources to increasing the number of 
needle exchange programmes and rehabilitation 
places across the country where it is needed most.
Action 34 of the NDS calls for the expansion 
of availability and access to needle exchange 
services as required. At the time of writing 
(March 2011), the nationwide needle exchange 
programme planned for 65 pharmacies (funded 
by a grant from the Elton John AIDS Foundation) 
has not been rolled out as the HSE and the Irish 
Pharmacy Union are still negotiating fi nal terms.
Action 32 of the NDS calls for an integrated 
national treatment and rehabilitation service 
for all substance users. In 2007, the HSE 
Working Group on residential treatment 
and rehabilitation reported a shortfall of 104 
inpatient detoxifi cation places and 252.5 
rehabilitation places.4
(Johnny Connolly, Brigid Pike, Martin Keane and 
Suzi Lyons)
1. Fine Gael and the Labour Party (2011) 
Government for National Recovery 2011–
2016. www.taoiseach.gov.ie
2. Director of Public Prosecutions v Connolly. 
[2011] IESC 6. Supreme Court Record No. 
478/2009. Date of delivery 15/02/2011. 
www.courts.ie/Judgments.nsf/Webpages/
HomePage?OpenDocument&l=en
3. Department of Justice, Equality and Law 
Reform (2010) Review of the Drug Treatment 
Court. Dublin: Stationery Offi ce. Available at 
www.justice.ie
4. Corrigan D and O’Gorman A (2007) Report 
of the HSE Working Group on residential 
treatment and rehabilitation. Dublin: Health 
Service Executive. 
www.drugsandalcohol.ie/6382
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In February 2011 Ireland elected a new government, which 
very quickly published its ‘programme for government’ 
for the next fi ve years. It also immediately disbanded the 
Department of Community, Equality and Gaeltacht Affairs, in 
which the Offi ce of the Minister for Drugs was located. At the 
time of going to press, however, the government had not 
announced its intentions with regard to the future location of 
the Offi ce of the Minister for Drugs and its functions. 
Drugnet Ireland looks back at how roles and responsibilities 
in relation to the drugs issue have been organised at national 
level since the fi rst national policy document on the drugs 
problem in Ireland was published forty years ago.1 Lead 
ministerial and departmental responsibility was assigned 
as follows.
1960s–early 1990s: The Minister for Health and his 
department initiated work leading to the 1971 Report of the 
working party on drug abuse, which recommended a series of 
initiatives to reduce the use of drugs and to help rehabilitate 
people who had acquired a drugs habit, and to the 1991 
Government strategy to prevent drug misuse, which included a 
range of supply and demand reduction measures. 
Mid 1990s: The Department of the Taoiseach became 
the centre of activity when the government established a 
Ministerial Task Force on Measures to Reduce Demand for 
Drugs under the chairmanship of the Minister of State to the 
Government, Pat Rabbitte  TD. The two reports of this task 
force, published in 1996 and 1997, marked a turning point 
for Ireland’s drugs policy, with the government recognising 
for the fi rst time the link between problem drug use and 
socio-economic disadvantage and the need to involve local 
communities in tackling the problem.
1997–2002: The Department of Tourism, Sport and 
Recreation (DTSR) was given lead responsibility because 
it also had responsibility for local development and for 
co-ordinating a number of programmes promoting social 
inclusion, and was considered well placed to lead on the 
new strategic direction. A Minister of State within DTSR 
was given specifi c responsibility for implementing the 
recommendations in the two Ministerial Task Force reports. 
The Steering Committee that drafted the National drugs 
strategy 2001–2008 recommended that lead responsibility 
stay with the DTSR despite the fact that the Department 
of the Taoiseach or the Department of Health, because of 
either political authority or budget size, would have wielded 
considerable infl uence in furthering the drugs strategy. The 
Steering Group took the view that, as a service provider, 
the ability of the Department of Health to drive issues 
surrounding supply control and education and awareness 
issues would be limited, and that, conversely, the DTSR 
would be objective in relation to all the thematic areas 
covered by the national policy. 
2002–2011: The newly established Department of 
Community, Rural and Gaeltacht Affairs (DCRGA) 
(changed in 2009 to Department of Community, Equality 
and Gaeltacht Affairs) took over local and community 
development responsibilities from the former DTSR and 
therefore also responsibility for co-ordinating the national 
drugs strategy. Between 2002 and 2007 a Minister of State 
within DCRGA was given special responsibility for the drugs 
strategy, and also for housing and urban renewal, which was 
administered by the then Department of the Environment 
and Local Government; between 2007 and 2010, the 
Minister of State with responsibility for the drugs strategy 
was given responsibility for community affairs, administered 
by DCRGA, in lieu of housing and urban renewal. Following 
a Cabinet reshuffl e in 2010, the drugs strategy was included 
in the responsibilities of the Minister for Community, 
Equality and Gaeltacht Affairs, Pat Carey TD, who had been 
Minister of State with responsibility for the drugs strategy 
and community affairs for 11 months in 2007/2008. 
Over the years, three main groups of actors have been given 
responsibility for developing Ireland’s drugs policy. To begin 
with, the need to include expertise seems to have been the 
guiding principle – the working party on drug abuse set up 
in 1968 comprised four civil servants, fi ve representatives of 
statutory and local agencies, four independent professionals, 
one university academic and two university students. In 
1983 and again in 1996, the need for political engagement 
was considered paramount: two task forces comprised 
entirely of ministers of state, for example, for health, 
education, justice, environment, foreign affairs, labour and 
social welfare, were set up to review the drugs problem and 
to make recommendations. The recommendations of the 
1983 ministerial task force were never published although it 
is understood that, like the 1996/97 ministerial task force, it 
recognised the link between problem drug use and socio-
economic disadvantage.2 
Since the 1990s, government offi cials have gradually 
assumed a greater role in developing drug policy. In 1990 
a Minister of State at the Department of Health chaired 
the committee, comprised entirely of senior civil servants, 
which drew up the 1991 Government strategy to prevent 
drug misuse. Subsequently, the 2001–2008 and 2009–2016 
national drugs strategies were drawn up by ‘groups’ of 
senior departmental and state agency offi cials, together 
with a representative each of the voluntary and community 
sectors, which were chaired by a senior civil servant. 
These groups worked within terms of reference set by the 
government, consulted widely with experts and the public, 
and submitted their reports for approval by the government.
Since the mid 1990s, politicians have sought to maintain 
oversight by means of committees. In 1997 a Cabinet 
Committee on Social Inclusion and Drugs was established, 
chaired by the Taoiseach, and comprising government 
ministers with relevant responsibilities. In recent years the title 
of this committee has evolved into the Cabinet Committee 
on Social Inclusion, Children and Integration. The 2001–2008 
National Drugs Strategy called for the establishment of a 
dedicated drugs sub-committee of the existing Oireachtas 
Committee on Tourism, Sport and Recreation, which would 
meet at least three times a year. This did not happen, and the 
Steering Group that reviewed the national drugs strategy in 
2005 recommended that rather than set up a specifi c sub-
committee, the Minister of State meet with the full Oireachtas 
Committee to discuss the Strategy and its implementation 
twice a year. This did happen.
The need for expert advice has always been acknowledged, 
starting with a call from the 1968–1971 Working Party on 
Drug Abuse for the establishment of a ‘permanent advisory 
body’.2 Currently the National Advisory Committee on Drugs 
(NACD) fulfi ls this function. Comprising representatives 
from academic disciplines, professional practitioners, civil 
and public servants, and representatives of the voluntary 
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and community sectors, it advises the government, based 
on its analysis and interpretation of research fi ndings. The 
2009–2016 National Drugs Strategy called for the NACD 
to be brought within the ambit of the new Offi ce of the 
Minister for Drugs (OMD): the intention was ‘to better 
address the issue of linkages between policy development 
and research’, while also seeking to maintain the 
‘independence’ of the NACD.
The need for effective co-ordination was also fi rst 
acknowledged by the 1968–1971 Working Party on 
Drug Abuse and it has proved an ongoing challenge.3 
Most recently, the National Drugs Strategy 2009–2016 
signifi cantly simplifi ed and streamlined the mechanisms 
put in place to help co-ordinate the work of the local and 
regional drugs task forces. The objective was to establish 
a clear hierarchy and a greater transparency of roles, from 
government and cabinet committee down to local project 
level. This was sought by establishing an Offi ce of the 
Minister for Drugs (OMD) within the DCEGA, which would: 
• absorb the work of both the former Drug Strategy 
Unit in the DCRGA and the National Drugs 
Strategy Team; 
• introduce a ‘networked organisational’ structure, 
like that already operating in the Offi ce of the 
Minister for Children, and thereby remove the need 
for the Interdepartmental Group on Drugs (IDG);
• bring the director of the NACD onto the 
management team of the OMD; and
• report directly to the Cabinet Committee on Social 
Inclusion, Children and Integration.
To support ‘integration’, the Steering Group proposed 
three additional mechanisms: an Oversight Forum on Drugs 
(OFD), an Advisory Group of the OMD, and the holding 
of twice-yearly bilateral meetings between the Minister for 
Drugs and various stakeholders. This number of mechanisms 
begs the question, is there a more effi cient and effective 
means of engaging all stakeholders in the deliberation 
over and choice of policy options; for example, a single 
social partnership structure along the same lines as the 
National Economic and Social Forum (NESF) but focused 
on problematic substance use might perform such an 
integrating function. 
(Brigid Pike)
1. The policy documents cited in this article are available on 
the website of the National Documentation Centre on 
Drug Use at www.drugsandalcohol.ie  
2. For a full account, see Butler S (2002) Alcohol, drugs and 
health promotion in modern Ireland. Dublin: Institute of 
Public Administration, Chapters 5 and 6.
3. For a full account, see Pike B (2009) Development of 
Ireland’s drug strategy 2000–2007. HRB Overview Series 
8. Dublin: Health Research Board, Chapter 4.
From research to policy: the Sax 
Institute seminar
In February 2011 the Department of Health and Children 
and the Health Research Board (HRB) organised a two-day 
workshop and a one-day seminar examining the Australian 
experience of evidence-informed policy and knowledge 
brokering. The events were facilitated and presented by 
Professor Sally Redman and Ms Deborah Frew from the 
Sax institute in New South Wales, Australia 
(www.saxinstitute.org.au). 
Mr Jim Breslin, Department of Health and Children, and Mr 
Enda Connolly, Heath Research Board, opened the seminar. 
Mr Breslin said that the seminar would provide strategies 
that would assist policy makers to direct and use research 
to inform policy and would enable researchers to complete 
research that was relevant to policy making. Mr Connolly 
reported that the HRB’s Strategic Business Plan 2010–14 will 
increase the Board’s investment in population health and 
health services research and facilitate the Department in 
locating and using this and other appropriate research. 
Staff working in the HSE Dublin North East addiction 
services recently bid a fond farewell to Mary Fanning, 
director of nursing, on her retirement. Mary joined the 
addiction services in 1998 as a clinical nurse manager and 
in 2000 became director of nursing for addiction services 
of the former Northern Area Health Board. During this 
time Mary was instrumental in the development of clinical 
nursing services within treatment centres and oversaw the 
development of many clinical nurse specialist roles. These 
included hepatitis C liaison, drug liaison midwifery and drug 
courts specialist nursing posts. 
At a function held in City Clinic to mark the occasion, 
Dr Bríon Sweeney, medical director of the addiction 
services, paid personal tribute to Mary and acknowledged 
her contribution to the development of services over the 
years. These sentiments were echoed by colleagues both 
past and present. 
We wish Mary a long and happy retirement and every 
success with any future pursuits she engages in. 
(Vivion McGuire)
Retirement of Ms Mary Fanning
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two-way bridge between policy (makers) and research(ers). 
Her research in this area in 2003 found that policy makers 
wanted research that was timely, relevant, of high quality 
and easy to understand. In addition, policy makers wanted 
research that found specifi c, acceptable and appropriate 
evidence-based solutions to problems. Dr Redman identifi ed 
three ways in which policy makers and researchers interact: 
the scientifi c approach (where researchers do and publish 
research and policy makers are responsible for locating and 
using it), the advocacy approach (where researchers do 
research and lobby for its use in policy) and the partnership 
approach (where policy makers and researchers decide the 
research needs together). There is not enough evidence to 
identify which, if any, approach is best. 
The partnership approach appears to enhance exchange 
of knowledge between policy makers and researchers. Ms 
Frew reported that the Sax Institute uses Lomas’s defi nition 
of knowledge brokering, which identifi es the broker as an 
intermediary between research(er) and policy (maker).1 The 
knowledge broker can be an institution or a person. The 
knowledge brokers at the Sax Institution are experienced 
both as researchers and as policy makers. The interventions 
that facilitate good knowledge brokering are structured 
process, strict parameters and feedback. A knowledge 
brokering session is most effective when the policy maker is 
clear about their needs, and the broker establishes a rapport 
with the policy maker, listens to their needs and clarifi es 
research questions with them. 
Ms Frew described the rationale for the Sax Institute 
Knowledge Transfer and Communications Programme. In 
2003, the Institute found that 39% of policy makers believed 
that research was not relevant to policy; 87% said that 
research was not presented in a useful format; and only 5% 
had ever used research to inform policy. Seventy-two per 
cent of policy makers wanted brief research summaries. The 
Institute developed an evidence check process to facilitate 
a review of existing research and evidence tailored to the 
specifi c needs of the policy maker. Since 2003 the Institute 
has completed 90 evidence reviews on a wide variety of 
topics. Each review takes approximately eight weeks to 
complete. The Institute follows up on the use of  evidence 
reviews three months after they are completed to determine 
satisfaction with the process and how the review is used. 
The Department of Health and Children has asked the HRB 
to complete a number of evidence reviews by September 
2011 using the evidence check process. 
(Jean Long)
1. Lomas J (2007) The in-between world of knowledge 
brokering. British Medical Journal, 334(7585): 129–132.
From research to policy: the Sax Institute seminar  (continued)
Involving service users: the Irish experience
Action 42 of the National Drugs Strategy 2009–2016 
identifi es the need to further involve the users of drug 
treatment services, ‘both as an essential part of clinical 
governance procedures and service planning’ (para. 4.79). 
The issues to be considered when involving service 
users are highlighted in a recent qualitative study of 
service user involvement in a Dublin-based methadone 
maintenance service.1
Completed in mid-2008, this study was based on in-depth 
semi-structured interviews with eight providers from the 
service, three drugs task force co-ordinators and the co-
ordinator of the drug-user group, and eight service users 
attending different clinics across the broad geographical area 
in which the service operated. The author, Aoibhínn King, of 
the School of Social Work and Social Policy, Trinity College, 
Dublin, identifi ed issues around fi ve themes:
1. Purpose of the service: There were confl icting views 
about the purpose. Service users were clear that 
the purpose was to contribute to a reduction in the 
diffi culties they experienced through drug use and 
to the stabilisation and normalisation of their lives. 
Service providers were more ambivalent: while many 
saw abstinence as the fi nal goal, they claimed that 
harm reduction and improved quality of life were the 
actual outcomes.
2. Understanding of user involvement: While there 
was overall consensus that user involvement was 
both progressive and desirable, and increased the 
effectiveness of the service, in reality, service users’ 
experience was that the system did not engage with 
them: ‘I’m not involved at all, like they haven’t asked me 
to do anything, just come up and get me methadone.’ 
3. Determining own care: Respondents generally 
endorsed the principle that service users have valuable 
knowledge and experience that can help in planning 
and delivering their care programme, but they were 
almost unanimous in stating that, in practice, service 
users played little or no part in determining their own 
treatment. Moreover, there was a prevailing view that 
both service users and service providers gave higher 
priority to issues around methadone maintenance 
than to addressing the issues which impacted on the 
individual’s life and infl uenced their drug use. 
4. Involvement in service evaluation, planning and 
development: Involvement was perceived as largely 
symbolic. Several obstacles were identifi ed, including 
resource constraints, organisational and national 
protocols and procedures, unrealistic expectations on the 
part of service users, disillusionment and fear of criticism 
on the part of service providers. The author also noted, 
‘the culture within services served as the most signifi cant 
barrier to meaningful collaboration’.
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6Organising drug users: insights from Britain
In a recent study of health and society in Britain since the 
1960s,1 the purpose of which was to explore the changing 
pattern of relationships between the state and civil society, 
authors Alex Mold and Virginia Berridge describe how 
groups representing drug users have emerged in the last 
decade in response to ‘state-directed user involvement’, such 
as that described in the preceding article on the involvement 
of service users in a Dublin methadone programme. Mold 
and Berridge identify three categories of user groups in 
Britain – service users, activist users, and carers (principally 
parents and families of users). 
With regard to the fi rst category, the authors outline how 
service users started to form groups as the state began 
taking a greater interest in the views of users. They found 
there were limits to how far the state was prepared to 
listen to the views of users: they use the term ‘tokenism’ 
to describe the nature of the engagement. A separate 
study of the role of service user groups in a sample of drug 
action teams (DATs) in England2 found that these groups 
were experiencing problems with long-term sustainability, 
owing to short-comings in their governance arrangements. 
The researchers concluded, ‘...groups established within 
an agency for the purpose of user involvement (UI) 
must have adequate resources to meet a well-defi ned 
objective. Management processes, leadership and lines of 
communication must be clear. User self-organizations ought 
to be invited and enabled to contribute to UI in a manner 
that promotes sustainability of the group and meets clearly 
defi ned objectives without compromising their self-defi ned 
purpose. The power imbalance that is inherent in UI in the 
drugs-treatment fi eld must be explicitly addressed’ (p. 96).
Mold and Berridge describe how, in parallel to the 
emergence of service user groups, drug users in Britain also 
began to organise in activist user groups. While interested in 
issues of service provision, these groups are also interested 
in broader social and political issues such as identity, 
rights, empowerment and drug policy. These groups have 
encountered diffi culties including inability to access funding 
and the inability of a disparate membership to agree 
common positions. 
The authors note that, at the international level, drug users 
have also become more vocal, participating in drug policy 
conferences and lobbying international policy bodies. 
Examples include the International Network of People who 
Use Drugs (INPUD), which is supported by the International 
Harm Reduction Association (IHRA), and the European 
Network for Just and Effective Drug Policies (ENCOD),3 
which lobbies the institutions of the European Union, and 
the United Nations Commission on Narcotic Drugs (CND). 
However, such groups experience greater diffi culties than 
other NGO groupings in obtaining accreditation.
Looking to the future, the authors suggest that the way 
in which citizens who also use drugs will contribute to 
the ongoing debate on policy in relation to psychoactive 
drugs will depend to a great extent on the direction that 
drug policy takes. They identify two opposing trends in 
Britain’s drug policy: one moving in favour of abstinence 
and a tougher stance on drug use, and one moving towards 
liberalisation and the establishment of drug use as a human 
‘right’. The authors see the recent push towards abstinence 
as undermining the position of activist users who have 
sought to reclaim drug use as a legitimate practice and 
identity, while more coercion in drug treatment is seen as 
running counter to efforts to win greater choice and more 
rights for patients. 
The authors conclude, ‘It is impossible to say which direction 
drug policy will move in, but it is certain that voluntary 
organisations, however reconstituted and reconfi gured, 
will play a key part in whatever is to come’ (p. 178). 
(Brigid Pike)
1. Mold A and Berridge V (2010) Voluntary action and 
illegal drugs: health and society in Britain since the 1960s. 
Basingstoke, Hants: Palgrave Macmillan.
2. Patterson S, Weaver T and Crawford M (2010) Drug 
service user groups: only a partial solution to the 
problem of developing user involvement. Drugs: 
education, prevention and policy, 17(1): 84–97.
3. For more information on these international activist user 
organisations, visit www.inpud.net and www.encod.org
5. Operational system and interactions between service 
users and service providers: The author found that 
the staff attitudes common under the ‘old system’ of 
treatment still pervaded the culture in treatment services 
and was the main impediment to the active engagement 
of service users. Staff tended to defi ne service users in 
negative stereotypical terms, and service users, in turn, 
characterised their relationship with treatment systems 
primarily in terms of fear, rather than terms of equality 
or mutuality. 
King described the explicit acknowledgement of the 
imbalance of knowledge and power between provider 
and user as ‘remarkably stark’. While the service studied 
was nominally imbued with the harm reduction ethos, the 
author found that the underlying philosophy of the old drug 
treatment system had not shifted to any great extent. 
To bring the treatment service into line with harm reduction 
philosophy, King concluded that much more was needed 
than simply including abstract statements of principle in 
offi cial policy documents: ’It may be that what is needed is a 
more explicit and committed approach which incorporates 
the education and training of all involved in the delivery 
of treatment services for illicit drug users, if the situation 
identifi ed here is not to persist’. 
(Brigid Pike)
1. King A (2011) Service user involvement in methadone 
maintenance programmes: the ‘philosophy, the ideal 
and the reality’. Drugs: education, prevention and policy. 
[Early online PDF, 7 Sep 2010]. 
http://informahealthcare.com/toc/dep/0/0
Involving service users  (continued)
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an interactive workshop
On 14 January 2011 Tallaght Drugs Task Force hosted an 
interactive workshop, ‘Building a service user voice’, in co-
operation with the Tallaght Service Users Forum. The Forum 
was established in 2005 with three goals: to be an effective 
strategic and professional committee/forum; to engage, 
inform and hear the voice of service users; and to support 
the partnership of service users and service providers to 
enhance service design and delivery. 
During the workshop, participants got the opportunity to 
work in groups with members of the Forum and service 
providers as well as representatives from the voluntary and 
statutory bodies. Each of the working groups explored 
barriers to service-user participation and what could be done 
to overcome them. 
The Forum has set as additional goals for 2011:
 ■ advertise the forum and its work;
 ■ maintain good communication with service providers;
 ■ run courses and workshops for service users;
 ■ organise outreach projects;
 ■ meet service users and support them;
 ■ provide information on how to access treatment services.
Further information on the Service Users Forum and other 
services offered by Tallaght Drugs Task Force can be accessed 
on the Task Force website www.tallaghtdtf.ie. 
(Vivion McGuire) 
This section contains short summaries of recent reports and 
other developments of interest.
ISPCC survey of young people’s alcohol use
In December 2010 the Irish Society for the Prevention of 
Cruelty to Children (ISPCC) published the results of a survey 
they conducted among 9,746 young people aged 12–18 
years in 2009.1 This survey examined young people’s alcohol 
use, their attitudes towards teen and parental alcohol use 
and the effects of parental alcohol use on their lives, and 
included young people from 84 educational institutions (70 
secondary schools, eight primary schools and six Youthreach 
centres) across Ireland.
Over two fi fths (45%) reported that they drink alcohol and 
25% reported they had engaged in binge drinking in the 
two weeks prior to the survey. As the data in the report are 
not presented by age it is not possible to compare drinking 
trends between younger and older respondents.
The survey also questioned young people on their attitudes 
and beliefs about their own alcohol use and about their 
parents’ drinking; 56% stated that they did not believe it 
was ‘okay’ for teenagers to drink alcohol to get drunk and 
79% disagreed with parents drinking alcohol and becoming 
drunk in front of their children. 
One in ten stated that their parent/guardian’s alcohol use 
affected their life. The effects of parental drinking described 
by the respondents included emotional impacts, abuse and 
violence, impacts on family relationships and changes in 
parental behaviour. 
 Filling a gap at BAAG
Bluebell Addiction Advisory Group (BAAG) was founded 
in 2004. The organisation provides programmes such as 
the Get Active Group (GAP) for women and the Men’s 
Gardening Group. GAP aims to fi ll the gaps left by addiction, 
such as boredom, isolation and depression, through a 
programme of activities designed to tap into hidden talents 
and build on existing interests.
GAP members took part in a six-week cookery course with 
chef Yves Tastet and produced a cookbook that focused on 
nutrition and healthy eating as a way of avoiding health 
problems such as depression, low energy levels and liver 
disease. The cookbook, Filling a gap at BAAG,2 was launched 
by the Canal Communities Local Drugs Task Force in 2010. 
Members of the group have visited other task force projects 
and recreated dishes from the cookbook in an effort to 
motivate others to make nutrition and health a priority in 
their recovery. A catering service run by GAP has catered 
for up to 100 people at events organised by Dublin City 
Council, Canal Communities Local Drugs Task Force, Rialto 
Youth Project and the Community Lynks Project. 
GAP works in partnership with the Men’s Gardening Group 
to create jobs within the local community. The men’s group 
grows fruit and vegetables which are bought by GAP for 
their catering business. The groups recently worked together 
to acquire skills in producing Christmas wreaths and table 
centre pieces. The groups are currently working together 
planting fruit trees and will produce jam for community sales 
in the future.
The group has taken ownership of its activities; members 
carry out duties and roles, including those of cookbook tour 
co-ordinator, leafl et and business card design and donations 
manager. GAP provides summer camps and events for 
members’ children so that the women can continue in their 
programme during school holiday periods. 
(Contributors: Deirdre Mongan and Anne Marie Carew)
1. Irish Society for the Prevention of Cruelty to Children 
(2010) If they’re getting loaded why can’t I? Dublin: 
ISPCC. www.drugsandalcohol.ie/14344 
2. Get Active Group (2010) Filling a gap at BAAG. Dublin: 
Bluebell Addiction Advisory Group.
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8Figure 3 (p. 24) in the article ‘Drug-related crime 
statistics’ was incorrectly labelled owing to a production 
error. The correctly labelled fi gure is shown opposite.
Correction to article in Drugnet Ireland 36 (Winter 2010)
Figure 3 Trends in the total number of drug seizures 
and cannabis seizures, 2005–2009 
Source: Compiled by the Forensic Science 
Laboratory drug section and reported by the 
Central Statistics Offi ce
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Twelfth annual Service of Commemoration 
and Hope 
On Tuesday 1 February, the Family Support Network held 
its twelfth annual Service of Commemoration and Hope, 
entitled ‘Reclaiming Family Through Rehabilitation’, in 
remembrance of loved ones lost to drugs and related causes 
and to publicly support families living with the devastation 
that drug use causes.
The service in Our Lady of Lourdes Church, Sean McDermott 
Street, was attended by President Mary McAleese, Mr Pat 
Carey TD, Minister of State, Commander Mick Treacy, aide 
de camp to the Taoiseach, and Bishop Eamon Walsh and 
other religious representatives, as well as family members, 
friends and representatives from family support groups 
throughout the island of Ireland and in Scotland, and many 
people working in this area. 
Sadie Grace of the Family Support Network highlighted the 
important role families play in the rehabilitation process, and 
the need for rehabilitation services to recognise that families 
also require help and support. She said it was important for 
the next government to prioritise the drug issue and the 
value of family support.
Minister Carey, in an emotional speech, stated that the 
Family Support Network is a vital part of the National Drugs 
Strategy, and emphasised the importance of the single 
strategy on alcohol and substance misuse being delivered as 
soon as possible.
President McAleese recited the poem ‘For Lost Friends’ by 
John O’Donohue. Bishop Walsh, Fr Edmond Grace and 
Ruaidhri McAuliffe, representing the drug users’ forum 
UISCE, also addressed the gathering. 
For many families, this service is the fi rst time that they 
can openly grieve for their loved ones lost to drug use and 
related causes. Personal testimonies were given by members 
of family support groups, refl ecting the support received 
through these groups. Music was provided by the Gardiner 
Street Gospel Choir.
(Ena Lynn)
 Contact the Family Support Network at 16 Talbot Street, 
Dublin 1. Tel: 01 836 51 68; email: info@fsn.ie; web: 
www.fsn.ie
drugnet 
IRELAND
President Mary McAleese speaking at the service
9Health and homelessness: the Simon 
snapshot study
The Simon Communities of Ireland published a report on 
health and homelessness in late 2010.1 This report presents 
the fi ndings of a ‘point in time’ survey undertaken between 
26 July and 1 August 2010 at all eight Simon Communities 
in Ireland. The survey collected data on the profi le and 
health needs of people using Simon projects and services 
over a one-week period. 
Methods of data collection
Data for the 788 questionnaires were collected in face-to-face 
interviews and in a review of the records of the individuals 
using the projects and services during the one-week period. 
The survey respondents were selected through convenience 
sampling, which is a sample of the population selected 
because it is close at hand and readily available. Sampling of 
this nature can provide useful insights into the health needs 
of a proportion of the people using Simon services but the 
data generated from such a sample cannot be generalised 
to the health needs of the wider homeless population. Data 
were collected from three types of service users: 
 ■ those who were currently homeless;
 ■ those who had been homeless and needed support to 
maintain their current home;
 ■ those who were at risk of becoming homeless.
Profi le of the sample 
78% were male.
85% were Irish, 6% were British, 5% were Eastern European 
and 1.4% were Irish Travellers.
9% were aged between 18 and 25, 21% were aged between 
26 and 35 and 54% were aged between 36 and 55.
51% received a disability allowance and 6% received the old 
age pension. 
6.5% were classifi ed as not being habitual residents. 
65% were registered as homeless with the local authority. 
Duration of homeless experience
Of the 471 people presently homeless; 20% were homeless 
for six months or less, 45% for between seven months and 
fi ve years, and 35% for more than fi ve years. 
Of the 146 people who were formerly homeless and 
who were now being supported by Simon Tenancy 
Sustainment services, 58% reported being homeless for 
more than three years. 
Thirty-fi ve per cent (277) were currently living in 
vulnerable situations, such as rough sleeping, emergency 
accommodation, squats and bed and breakfasts. 
Fifty-seven per cent (449) were currently living in 
accommodation with some level of support; this included 
high-support housing, low-support housing, local authority 
accommodation with support, the private rented sector with 
support and transitional accommodation. Only 6% were 
living independently with no support. 
Reasons for fi rst becoming homeless
When responses on primary and secondary reasons for 
becoming homeless in the fi rst instance were combined and 
analysed together, the main reasons given were personal 
alcohol use (19%), family confl ict (14%), personal drug use 
(12%) relationship breakdown (9%) and personal mental 
health problems (7%). 
Physical health conditions
Fifty-six per cent (442) of the respondents had at least one 
diagnosed physical health condition. The most common of 
these were: 
• 123 cases of cardiovascular disease, including angina, 
hypertension and stroke;
• 115 cases of infectious disease, including (most 
commonly) hepatitis C, and also hepatitis B, HIV, 
sexually transmitted infection, tuberculosis and 
urinary tract infection;
• 88 cases of injury, including head injury, broken 
bones and cuts;
• 74 cases of respiratory disease, including asthma, 
chronic obstructive pulmonary disease, pneumonia 
and pleurisy; 
• 45 cases of neurological disorder, including epilepsy. 
Parkinson’s disease, motor neuron disease, spinal 
muscular atrophy and muscular dystrophy.
Thrity-six per cent of respondents reported one or more 
undiagnosed physical health problem. 
The report points out that this data may suggest ‘that the 
experience of homelessness has a signifi cant negative 
impact on the physical health of people and that their 
health status signifi cantly deteriorated since the start of their 
homelessness experience’. 
Diagnosed mental health conditions
Fifty-two per cent (411) of the respondents had at least one 
diagnosed mental health condition; 29% reported having 
depression, 9% schizophrenia, 7% panic attacks, 5% social 
anxiety disorder, 4% mild cognitive impairment and 3% 
bi-polar disorder.
Forty-four per cent of respondents reported one or more 
undiagnosed mental health conditions. 
Alcohol and drug use
Of the 769 people who answered the question, 66% 
reported consuming alcohol. Fifty-fi ve per cent of 
respondents had physical complications as a result of alcohol 
use. Of the 768 responses, 38% reported using drugs other 
than alcohol. Heroin was the most common other drug 
used, followed by cannabis (Table 1 overleaf). Thirty-one per 
cent of respondents who used drugs were using two drugs 
at the same time and 25% were using three drugs. Fifteen 
per cent (115) of all respondents were intravenous (IV) drug 
users. Seventy-eight respondents were tested for blood 
borne viruses. 
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Table 1 Drugs most commonly used by survey 
respondents (n=768)
n %
Heroin 159 20.7
Cannabis 116 15.1
Benzodiazepines 
(prescription status not reported) 94 12.2
Head shop substances 54 7.0
Methadone (unprescribed) 53 6.9
Cocaine 17 2.2
Other 24 3.1
Unknown 13 1.7
Complex needs
The report outlines the presence of a range of complex needs 
among the service users who participated in the research. 
For example, 28% had at least one diagnosed physical and 
at least one diagnosed mental health condition, and 28% 
were diagnosed with a mental health condition and reported 
complications arising from alcohol and/or drug use. 
Challenging behaviour
The majority (65%) of homeless people do not present with 
challenging behaviour (such as withdrawn aggressive or 
violent behaviour). 
Suicide and self-harm
Fifteen per cent of respondents reported self-harming 
episodes at the time of the survey, 23% reported suicide 
ideation and 8% had attempted to commit suicide in the six 
months prior to the survey. 
Service use
The overwhelming majority of survey participants (84%) 
were medical card holders and 91% were registered with 
a general practitioner. Sixteen per cent of respondents 
who answered the question had attended accident and 
emergency services in the last month, 20% had attended an 
out-patient hospital department and 8% had been admitted 
to hospital. 
Comparisons with other studies
More men, older people and people from outside Ireland, 
and a higher proportion of people on disability allowance, 
attend Simon Community services than observed in studies 
of other homeless services.2–4 The proportion registered 
as homeless was similar to that in the NACD study.3 The 
reasons given for becoming homeless were the same across 
the comparison studies, but the proportion reporting each 
reason was different, refl ecting age and gender differences 
between study groups. The proportion with diagnosed 
physical and mental health conditions was lower in the 
Simon study than in comparison studies, possibly because 
the Simon study included users of a broad range of services 
(including supported housing), while other studies tended to 
include users of emergency accommodation. The proportion 
reporting alcohol use was similar to that in other Irish 
studies. The drug use data in the Simon study did not allow 
for comparison with that in other studies. 
(Martin Keane and Jean Long)
1.  Simon Communities of Ireland (2010) Health and 
homelessness: health snapshot study of people using 
Simon services and projects in Ireland. Dublin: Simon 
Communities of Ireland. www.drugsandalcohol.ie/14750
2. Homeless Agency (2008) Counted in, 2008: a report on 
the extent of homelessness in Dublin. Homeless Agency 
Partnership, Dublin. www.drugsandalcohol.ie/11718
3. Lawless M and Corr C (2005) Drug use among the 
homeless in Ireland: a report for the National Advisory 
Committee on Drugs. Dublin: Stationery Offi ce. 
www.drugsandalcohol.ie/5950
4. O’Carroll A and O’Reilly F (2008) Health of the homeless 
in Dublin: has anything changed in the context of 
Ireland’s economic boom? European Journal of Public 
Health, 18(5): 448–453. www.drugsandalcohol.ie/12519
Health and homelessness  (continued)
The St Dominic’s Housing Association (SDHA) recently 
commissioned research to examine the applicability of the 
Housing First model to people with substance misuse issues, 
and to identify best practice in relation to supports needed 
to ensure tenancy sustainment for this vulnerable group. The 
resulting work was undertaken by independent consultant 
Simon Brooke and a report was published by the SDHA in 
January 2011.1 
The work included reviewing a selection of studies, and 
consultations with nine organisations and twelve service 
users. Chapter one of the fi nal report details the emergence 
of the Housing First approach in the US, and examines 
the evidence base for its effectiveness in comparison to 
traditional approaches. The defi ning feature of the Housing 
First approach is its focus on assisting homeless people 
to move into permanent accommodation and providing 
appropriate support services to sustain them in their 
tenancy. In contrast to traditional approaches, the Housing 
First approach does not require people to be abstinent from 
substance use prior to securing accommodation. 
The report cites a number of evaluations of the Housing First 
approach, most of which were done in the US. The evidence 
suggests that individuals participating in Housing First 
programmes spend less time homeless and in psychiatric 
hospitals and incur fewer costs to the health system than 
those availing of the traditional approach. The report cites a 
recent review which suggests that the evidence on Housing 
First for individuals with severe substance addiction is 
inconclusive.2 This is in part explained by the lack of studies 
comparing the Housing First approach with an alternative 
approach for individuals recruited on the basis of having a 
severe addiction to substances. As Brooke points out in the 
SDHA report, the inconclusive nature of the evidence does 
not suggest that the Housing First approach will not work 
Housing people who misuse substances 
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for people who misuse substances, but that more rigorous 
research is required to test its effectiveness with people 
with severe substance addictions. Nonetheless, the report 
does concur with the general consensus emerging from the 
literature that stable accommodation is an important factor 
in encouraging people to engage with treatment services 
and in achieving stability and abstinence. 
Practical issues to consider when housing people who 
misuse substances
The report outlines a number of practical issues that need 
to be considered when placing people with substance 
addictions in permanent housing. These issues were raised 
during consultations with stakeholders and were identifi ed in 
a number of reports from the UK which address this topic. 
Before moving in 
The report outlines a number of issues that need to be 
considered before potential tenants move into their new 
home, such as choice of location, the challenge of avoiding 
unwanted guests, and sensitivity to perceptions of neighbours.
The role of the landlord
There needs to be a clear understanding of the role of 
landlord and the visiting support team and good lines of 
communication between the two. This approach can 
ensure that any emerging issues around rent arrears or 
anti-social behaviour can be dealt with in a timely and 
professional manner. 
Housing-related supports
According to the author, in Ireland the housing-related 
supports for Housing First tenants will be provided by the 
Support to Live Independently (SLI) scheme delivered by 
Dublin Simon Community.
Isolation and loneliness
Loneliness and isolation were identifi ed as major problems 
experienced by people who misuse substances. According 
to Brooke, these people, who are mainly young single men, 
may fi nd themselves living in an unfamiliar area, perhaps 
living alone for the fi rst time, and at the same time cut off by 
choice from previous friends. 
The report highlights ongoing work in the UK on developing 
befriending and mentoring schemes as possible ways to 
reduce the isolation and loneliness experienced by this 
group when they move into stable accommodation. 
Meaningful activity during the day
Interviews with stakeholders revealed the importance of 
meaningful activity during the day for service users who 
are housed. Participation in Community Employment 
programmes and pursuing educational and recreational 
activities were mentioned by service users as appropriate 
activities; they also talked about the onset of boredom and 
potential relapse when their day lacked meaningful activity. 
Family and social contacts
The importance of family and social contacts were 
mentioned by stakeholders; equally, it was said that, in some 
cases, family contact would not be a realistic option in the 
medium or long term. 
Who is Housing First not appropriate for? 
The report contains a number of extracts from interviews 
with individual substance misusers. The general theme 
running through these accounts is that not all substance 
users will benefi t from the Housing First approach. 
Interviewees spoke about the diffi culties involved in 
managing the responsibility of paying bills and running a 
home while actively using drugs. They recalled both personal 
and anecdotal experiences of returning to the hostel or the 
street when the responsibility of maintaining their tenancy 
became compromised by substance use. A number of 
interviewees spoke about the problems of maintaining their 
tenancy while on crack cocaine. These accounts illustrate the 
need for effective fl oating support when people who misuse 
substances are placed in Housing First programmes. They 
require support with budgeting, cooking and other domestic 
chores and encouragement to engage with treatment. 
Conclusion
Brooke concludes by saying,
Although Housing First is largely untested in Ireland, 
and ... the specifi c case of people with substance misuse 
problems is less well researched than other groups, 
there is widespread belief among stakeholders in Ireland 
... that provided it is done properly, the Housing First 
approach can be successful for people with substance 
misuse problems. (p. 20) 
Ultimately, the approach requires a supply of affordable 
housing to be made available to house homeless people. 
To this end, and as outlined in this report, the Department 
of the Environment, Heritage and Local Government has 
established the Social Housing Leasing Initiative to release 
the large amount of empty properties for social housing. 
However, according to this report, ‘regrettably ... very little 
social housing has been produced by this scheme, which 
means that the Housing First approach is currently stalled’. 
(Martin Keane)
1. Brooke S (2011) Housing people who misuse substances: 
making Housing First work. Dublin: St Dominic’s Housing 
Association. www.drugsandalcohol.ie/14838
2. Kertesz SG, Crouch K, Milby JB, Cusimano RE and 
Schumacher JE (2009) Housing First for homeless 
persons with active addictions. Are we overreaching? 
The Millbank Quarterly, 87(2): 495–534.
Housing people who misuse substances  (continued)
drugnet 
IRELAND
Dublin / Mid Leinster (DML)
South
West
Dublin / North East (DNE)
12
Key result area Deliverable outputs 2011 Target completion
National Drugs 
Strategy (NDS)
2009–2016
Recruitment of clinical directors of addiction services completed in each of the 
four regions
Q3
Implementation of Phase 1 of interagency rehabilitation programmes in each 
of the four regions
Q3
Learning from reports implemented, including hepatitis C and intravenous 
drug users and methadone protocol
Q3
Pharmacy-located harm reduction/needle exchange services implemented 
throughout the country in each of the four regions
Q3
Alcohol public education/awareness campaign developed and launched Q2
Screening and brief interventions available in emergency departments and 
primary care services (Phase 1)
Q4
National Addiction Training framework in place for staff (Phase 1) Q3
National 
Homelessness 
Strategy
Protocols signposting referral pathways developed between specialist 
addiction/homeless/Traveller services and mental health and primary 
care services
Q4
All-Ireland Traveller 
Health Study
Screening programmes targeting vulnerable groups [among the Traveller 
population] devised and implemented
Q4
National Intercultural 
Health Strategy
Emergency multi-lingual aid toolkits for staff and intercultural health 
guide implemented 
Q3
Translation/interpreting toolkit for staff in line with Patient 
Charter implemented
Q2
LGBT Framework Good practice guiding principles developed to support LGBT communities 
in equitable access and use of health services
Q4
Source: HSE National Service Plan 2011, pp. 49–50
With regard to drug treatment, comparison with the 
2010 plan indicates that the HSE is seeking to maintain 
similar overall levels of activity and performance in 2011 
while increasing service provision in the South and West 
regions.2 No explanation for the changes in the levels of 
treatment supply and demand across the HSE regions is 
given in the plan.
Methadone treatment – The target for 2011 is to increase 
the total number of clients in methadone treatment outside 
prisons by 2.6%, from 8,278 to 8,500, and the number in 
treatment in prisons by three, from 497 to 500. While the 
number of clients in methadone treatment in the DML and 
DNE regions will rise by 1% (from 7,861 to 7,950), in the 
South Region the number is set to increase by 47% (from 
187 to 275), and in the West Region by 19.6% (from 230 
to 275).
Treatment of substance misusers over 18 years following 
assessment – In 2011 the total number of substance 
misusers over 18 years who will have commenced treatment 
following assessment is set to decline by 2%, from 1,380 to 
1,350. In the DML and DNE regions the number will decline 
by 67% (from 870 to 520), while in the South and West 
regions it will increase by 63% (from 510 to 830). 
HSE Regions
HSE plan for drug-related services in 2011 
The HSE National Service Plan 2011 sets out the agency’s 
plan in the drugs and alcohol area for 2011.1 A priority for 
the HSE Social Inclusion Services, which include addiction 
services, is to ‘continue to address the health impacts of 
addiction and/or substance misuse’. The Social Inclusion 
Services have also prioritised actions to enhance the health 
and well-being of other vulnerable groups, including the 
homeless, Travellers, ethnic minorities and members of the 
lesbian, gay, bisexual and transgender (LGBT) communities.
‘Deliverable outputs’ for 2011 are listed in the following table.
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In 2010 the target of ensuring that 100% of substance 
misusers over 18 years started treatment within one calendar 
month of assessment was not achieved: in the DML and 
DNE regions only 70.6% and 71.1% respectively entered 
treatment within the month, while in the South and West 
regions the proportions were 98.5% and 97.7% respectively. 
In 2011 the HSE will again try to reach the 100% target. 
Treatment of substance misusers under 18 years following 
assessment – In 2010 the total number of substance misusers 
under 18 years who commenced treatment following 
assessment exceeded the target of 115 by 18% (n=136). 
While the DML, DNE and South regions all came in on or 
under target, the West Region exceeded its target by 46% 
(65/30). 
The 2010 target of ensuring that 100% of substance 
misusers under 18 years commenced treatment within two 
weeks of assessment was met in the DML and DNE regions, 
but was not achieved in the South and West regions. In 
2011 the HSE has again set the target at 100% for all four 
HSE regions. 
Children and families
The 2011 plan sets out the HSE’s priorities and actions with 
regard to delivering its statutory services in the areas of 
children in care, after care and youth homelessness, and also 
with regard to maintaining and developing family support 
services and strengthening the provision of aftercare services. 
Specifi cally in relation to substance abuse, the service plan 
states that an ‘analysis of addiction services for children 
nationwide based on best practice’ will be completed in 
the fourth quarter of 2011. This action is in response to 
Recommendation 3 in the Report of the Commission to 
Inquire into Child Abuse (the Ryan Report), on the provision 
of counselling and educational services for children, which 
called on the HSE and the drugs task forces to establish 
addiction services for children nationwide based on best 
practice by June 2011.
Mental health
In the mental health area the HSE’s priorities in 2011 are to:
 ■ continue to implement elements of A vision for change, 
particularly reconfi guration of services from a model of 
care predicated on inpatient provision to a community-
based recovery model, reconfi guration of community 
mental health teams, development of clinical pathways 
and progressing the capital infrastructure,
 ■ implement measures to reduce suicide rates, and
 ■ enhance the provision of child and adolescent mental 
health services.
(Brigid Pike)
1. Health Service Executive (2011) National Service Plan 
2011. Available at www.hse.ie 
2. For an overview of the 2010 objectives, see Pike B (2010) 
HSE aims to strengthen drug services delivery. Drugnet 
Ireland, (34): 8–9.
Working together for better quality in 
drugs services 
To help ensure drug treatment and rehabilitation outcomes 
are achieved and to maintain a high standard of client 
safety, the National Drugs Strategy 2009–2016 calls for the 
introduction of ‘a clinical and organisational governance 
framework for all treatment and rehabilitation services in 
Ireland’ (Action 45). 
In collaboration with the HSE’s national offi ce of social 
inclusion, the Progression Routes Initiative (PRI), a voluntary 
agency co-located with the Ana Liffey Drug Project in North 
Inner-City Dublin, has developed a project to support 
community and voluntary organisations and groups to 
implement effective policies and develop services with the 
aim of assessing for themselves to what extent they meet the 
Quality Standards in Alcohol and Drugs Services (QuADS).1 
PRI supported 30 services in 2010, and is taking on another 
70 services in local and regional drugs task force areas in 
2011. The work is funded by the HSE and the North Inner 
City Drugs Task Force. While the supports are provided 
free of charge, management and staff in the participating 
services have spent on average three hours a week over the 
course of 2010 implementing the process. 
PRI works on the principle that quality is a journey, not a 
destination, a continuing process of self-refl ection, change 
and renewal, and individual organisations and groups are 
invited to set their own pace in relation to assessing their 
service as ‘QuADS compliant’. PRI points out that payback 
starts almost immediately as organisations that begin to 
work within a sound clinical and governance framework start 
to provide a more effi cient and effective service in a more 
economic, and enjoyable, manner. 
Becoming QuADS compliant, with the support of PRI, occurs 
in two phases. 
Self-review: Each organisation works through the QuADS 
framework, reviewing their policies and procedures against 
the template policies provided. The following supports are 
provided for this self-review and organisational 
change process: 
 ■ A ‘policy library’ is available on line. It contains more 
than 75 template policies, covering governance, human 
resources, service provision policies, service-user-related 
policies, and case management and care planning. 
These policies have been extensively researched and had 
editorial input from industry leaders from the health and 
commercial sectors. Participants are advised to adapt 
these policies to their own needs through an internal 
consultation process involving staff and service users. 
 ■ Service-specifi c facilitation and policy development is 
available on request. It is an effective way of engaging 
staff and management in the development of policies. 
Service-specifi c training modules are also available.
13
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 ■ Directors seminars for all participating organisations are 
held approximately every quarter to facilitate interagency 
best-practice learning.
Peer review: After completion of the self-review phase 
and the integration of quality standards and procedures 
into all aspects of operations, an organisation or group 
may request a peer review. Peer review is a relatively new 
way of promoting and supporting organisational and 
sectoral development. It has been used within therapeutic 
communities across Europe and also in the youth 
services sector. In the QuADS context it will involve two 
organisations from within the QuADS network auditing 
and evaluating the work of another organisation against 
a standardised framework, using a specially developed IT 
system. Over two days these reviewers will meet with service 
users, staff and managers and complete a policy and fi le 
audit. The reviewers will draft a comprehensive report that 
will assist the organisation under review to further improve 
its policies, systems and procedures. The reviewers will also 
present an overview of their fi ndings to a representative 
group of service users, staff and management, in order to 
ensure a cohesive and transparent process and to contribute 
to collective ownership of the QuADS approach.
The fi rst 30 services to participate in the PRI QuADS support 
project, the ‘2010 Group’, are currently completing Phase 1 
of the process. A working group drawn from the 2010 Group 
is now developing terms of reference for how peer review 
will work in Ireland. The group is aiming, with support from 
PRI, to trial the Phase 2 peer review process in 2011. 
Since its inception, the QuADS support project has seen a 
considerable rise in demand for participation from services 
around the country and as a result, there is a waiting list for 
participation in 2012.
PRI was set up fi ve years ago by Dublin’s North Inner 
City Local Drugs Task Force. Its purpose is ‘to connect 
interagency service delivery with national policy, promoting 
good practice through pilot initiatives and the provision 
of practical organisational supports’. The QuADS support 
project is just one of its projects. Others have included 
a community detox pilot and a case management pilot. 
These two pilots resulted in the development of protocols 
to enhance inter-agency working, and the production of 
a case management guidebook, jointly published with the 
Homeless Agency. 
(Brigid Pike)
Contacting Progression Routes 
Service providers seeking information on participating in 
a future round of the ‘QuADS compliance’ project should 
contact staff at Progression Routes. 
Caroline Gardner, 
Manager, 
pri@aldp.ie 
01 878 6899
Aoife Dermody / 
Martin Quigley, 
Development Workers, 
aoife.dermody@aldp.ie / 
martin.quigley@aldp.ie 
01 878 6899
Progression Routes has uploaded all its information and 
resources, including the QuADS policy library, on its website 
at www.progressionroutes.ie 
1. For more information on QuADS, see the Report of the 
HSE Working Group examining Quality & Standards for 
Addiction Services. The original QuADS document for 
the UK is available for download at 
www.drugscope.org.uk/OneStopCMS/Core/
SearchResults.aspx?SearchQuery=Quads
Working together for better quality in drugs services  (continued)
A one-day symposium on working together in mental health 
services took place on 11 February 2011 at Hotel Minella, 
Clonmel, Co Tipperary. This free event was part of the South 
Tipperary project for change in mental health services, and 
was open to all mental health professionals, carers and 
service users in South Tipperary and Carlow/Kilkenny areas. 
The symposium was supported by the HSE, the Department 
of Health and Children and the organisation Genio.1 
The speakers included: Prof Agnes Higgins, School of Nursing 
and Midwifery at TCD; Dr Pat Bracken consultant psychiatrist 
and clinical director, Centre for Mental Health Care and 
Recovery, West Cork; Mr Martin Doolan and Mr David 
Green, Assessment Careplanning Integrated Records (ACIR), 
South Tipperary Mental Health Service; Ms Lorna Ní Chéirín, 
DCU, Mental Health Trialogue Network Initiative (MHTNI2) 
in Clonmel; Mr Nick Bowles, trainer in solution-focused brief 
therapy (SFBT) and the developer of the award-winning 
‘Refocusing’ model for UK in-patient psychiatric units3; 
and Dr Yulia Kartalova-O’Doherty, researcher at the HRB.
Finding our way: working together in 
the mental health services
drugnet 
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Pictured at the symposium (l. to r.): Dr Yulia Kartalova-
O’Doherty, Prof Agnes Higgins, Mr Nick Bowles, Ms 
Lorna Ni Chéirín, Mr David Greene, Mr Martin Doolan, 
Dr Pat Bracken
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The symposium highlighted some exciting new initiatives 
in various mental health services, both in South Tipperary 
and elsewhere in Ireland, such as trialogue, ACIR, and 
the Centre for Mental Health in West Cork. One of the 
key messages of the symposium was that refocusing on 
recovery constitutes a big change and challenge for many 
service users, carers and service providers. Empowerment 
of all stakeholders is needed in order to support and sustain 
this major change. Promoting teamwork and successful 
communication are among other big challenges facing 
all mental health stakeholders. The symposium helped 
participants to share information about their innovative 
work, and to discuss opportunities and challenges facing 
mental health services in times of economic crisis. For more 
details about the symposium, please contact Dr Maeve 
Martin at Maeve.Martin@hse.ie . 
(Yulia Kartalova-O’Doherty)
1. Genio is a not-for-profi t organisation working with public, 
private and social sector organisations to ensure that 
people at risk of social exclusion are supported to live full 
lives in their communities. For details see www.genio.ie 
2. See www.mhtni.com/MHTNI/Home.html 
3. See http://preferredfutures.co.uk 
Finding our way  (continued)
Update on drug-related deaths and 
deaths among drug users in Ireland
National Drug-Related Deaths Index (NDRDI) fi gures on 
drug-related deaths and deaths among drug users reported 
in 2008 are now available on the web.1 Previously reported 
fi gures for the years 1998–2007 have been updated to 
include data received on new cases. Similarly, fi gures for 
2008 will be revised when data relating to new cases 
becomes available.
Between 1998 and 2008 a total of 4,064 drug-related deaths 
and deaths among drug users met the criteria for inclusion 
in the NDRDI database. Of these deaths, 2,434 were due 
to poisoning and 1,630 were due to traumatic or medical 
causes (non-poisoning) (Table 1).
Table 1 Number of drug-related deaths, by year of death, NDRDI 1998 to 2008 (N=4,064)
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
All deaths 241 270 258 277 338 296 368 454 503 535 524
Poisoning 
( n=2434) 177 186 179 177 211 185 206 251 271 298 293
Non-poisoning 
(n=1630) 64 84 79 100 127 111 162 203 232 237 231
Poisoning deaths in 2008
The annual number of deaths by poisoning increased from 
177 in 1998 to 298 in 2007, and dropped slightly in 2008 to 
293 (Table 1). Males accounted for the majority of deaths in 
each year; 72% of those who died by poisoning in 2008 were 
male. The majority of those who died in 2008 were aged 
between 20 and 44 years; the median age was 35 years.
In 2008 the greater proportion (61%) of all deaths by 
poisoning involved more than one substance (polysubstance 
cases), compared to 58% in 2007. The number of deaths 
where heroin was implicated rose to 86 in 2008, compared 
to 78 in 2007. Cocaine was implicated in 11% of all cases in 
the 11-year period, with the annual number dropping to 58 
in 2008, compared to 78 in 2007. Prescription and over-the-
counter medication was implicated in many of the deaths by 
poisoning. Benzodiazepines continued to play a major role in 
polysubstance poisonings.
For the fi rst time since 2003, the number of deaths by 
poisoning recorded inside Dublin (city and county) in 2008 
surpassed the number recorded outside Dublin. In 2008 
the highest number of poisoning deaths were recorded in 
the North Dublin City and County Regional Drugs Task 
Force area.
Non-poisoning deaths in 2008
The annual number of non-poisoning deaths among drug 
users decreased slightly to 231 in 2008, compared to 237 
in 2007 (Table 1). Since 2006 the number of non-poisoning 
cases recorded has steadied. Of the 221 cases in 2008 with 
a known cause of death, over half (54%, 120) were due to 
medical causes and the remainder (46%, 101) were due to 
trauma (Figure 1).
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Figure 1 Non-poisoning deaths among drug users, 
NDRDI 1998 to 2008 (N=1,468)
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Deaths due to trauma
The annual number of deaths due to trauma increased from 
40 in 1998 to 114 in 2007, but decreased to 101 in 2008 
(Figure 1). In 2008, sixty-one (60%) of those who died from 
traumatic causes were aged between 20 and 34 years. The 
median age was 28 years. Almost all (88, 87%) were male. 
The most common causes of death due to trauma were 
hanging and drowning.
Deaths due to medical causes
The annual number of deaths due to medical causes 
continued to increase steadily, reaching 120 cases in 2008, 
when it exceeded the number of deaths due to trauma 
(Figure 1).
The majority of those who died from medical causes in 2008 
were aged between 30 and 49 years. The median age was 
42 years. Three-quarters (352, 76%) of those who died were 
male. The most common medical causes of death in 2008 
were cardiac events (25, 21%), respiratory infections (16, 
13%) and liver disease (12, 10%).
(Ena Lynn, Suzi Lyons and Simone Walsh)
1. Health Research Board (2011) Drug-related deaths and 
deaths among drug users in Ireland: 2008 fi gures from 
the National Drug-Related Deaths Index. Available at 
www.drugsandalcohol.ie/14618
Update on drug-related deaths  (continued)
Trends in alcohol and drug admissions 
to psychiatric facilities
Activities of Irish psychiatric units and hospitals 2009, the 
annual report published by the Mental Health Information 
Systems Unit of the Health Research Board in December 
2010, shows that the total number of admissions to 
inpatient care has continued to fall.1 
In 2009, 1,993 cases were admitted to psychiatric facilities 
with an alcohol disorder, of whom 679 were treated for 
the fi rst time. Figure 1 presents the rates of fi rst admission 
between 1990 and 2009 of cases with a diagnosis of alcohol 
disorder. It is notable that the rate decreased fairly steadily 
in the years 1992 to 2004 and more than halved over the 
reporting period. The rate stabilised in 2004 and 2005, 
but decreased again in the years 2006 to 2009. The trend 
since the early nineties refl ects changes in the policy and 
practice of alcohol treatment, and the resultant increase in 
community-based and special residential alcohol treatment 
services. Of the 2,009 discharges of cases with an alcohol 
disorder in 2009, 50% spent 8 days or more in hospital. 
Whether or not these admissions were appropriate, and in 
line with the recommendations of the mental health policy, 
A vision for change, could not be discerned from the report 
as the numbers with co-morbid illness were not reported. 
In 2009, 824 cases were admitted to psychiatric facilities 
with a drug disorder, of whom 313 were treated for the fi rst 
time. The report does not present data on drug use and 
psychiatric co-morbidity, so it is not possible to determine 
whether or not these admissions were appropriate. Figure 
2 presents the rates of fi rst admission between 1990 and 
2009 of cases with a diagnosis of drug disorder. The rate 
was almost three times higher in 2001 than it was in 
1990. Notable dips in the rate occur in the census years 
1996, 2002 and 2006, and can be partly explained by the 
increased population fi gures used as the denominator in 
calculating the rate for those years. 
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The overall increase in the rate of drug-related fi rst 
admissions between 1990 and 2001 refl ects the increase 
in problem drug use in Ireland and its burden on the 
psychiatric services. The overall decrease in the rate since 
2001 possibly refl ects an increase in the provision of 
community-based specialised addiction services during this 
period. The increased rate in 2005 may be accounted for by 
the use of the 2002 census fi gure in calculating the rate. The 
decrease to 5.9 in 2006 refl ects the new census fi gure used 
as denominator. The rate increased in 2008 and 2009. Of 
the 847 discharges with a drug disorder, 50% spent six days 
or more in hospital. 
(Jean Long)
1. Daly A and Walsh D (2010) Activities of Irish psychiatric 
units and hospitals 2009: main fi ndings. HRB Statistics 
Series 9. Dublin: Health Research Board. 
www.hrb.ie/publications/hrb-publication/publications//535/
2. Annual reports from the National Psychiatric In-patient 
Reporting System (NPIRS) for the years 1990 to 2009 
are available on the Health Research Board website at 
www.hrb.ie/publications/mental-health
Trends in alcohol and drug admissions to psychiatric facilities  (continued)
Figure 1 Rates of psychiatric fi rst admission of cases with a diagnosis of alcohol disorder (using the ICD-10 three-
character categories) per 100,000 of the population in Ireland, NPIRS 1990–20092
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Figure 2 Rates of psychiatric fi rst admission of cases with a diagnosis of drug disorder (using the ICD-10 three-
character categories) per 100,000 of the population in Ireland, NPIRS 1990–20092
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Problematic alcohol use among methadone 
users: update on a HRB-funded study
Problematic alcohol use is common among injecting drug 
users and is known to be associated with adverse health 
outcomes. Recently published systematic reviews1 have 
demonstrated the role of primary care in screening and 
treatment for problematic alcohol use and the importance 
of a stepped approach to alcohol treatment, whereby 
hazardous or harmful alcohol use benefi ts from more 
intensive or specialised treatment. 
The UCD School of Medicine, in conjunction with the 
University of Limerick, Trinity College Dublin and HSE 
Addiction Services, is conducting a study on problem alcohol 
use among people with opiate dependency in primary care. 
The research team is led by Professor Walter Cullen and the 
study is funded by the Health Research Board (HRB).
The aim of the study, ‘Towards optimum care of problematic 
alcohol use among patients with opiate dependency’, is to 
inform and improve the screening and treatment of problem 
alcohol use among methadone users in primary care by:
• describing both users’ and providers’ experiences of 
and attitudes towards such screening and treatment;
• developing a complex intervention to improve 
screening and treatment rates;
• determining the views of professionals and 
patients regarding optimal implementation of this 
complex intervention.
This qualitative study is being carried out in three phases in 
the east coast. 
In the fi rst phase, 57 healthcare professionals and 
methadone users from 23 randomly selected GP practices 
and specialist addiction services were interviewed about their 
experience of and attitudes towards screening and treatment 
for problematic alcohol use.
In phase two, the researchers aim to develop clinical 
guidelines for screening and treatment for problem alcohol 
use among drug users. These guidelines will be informed 
by the fi ndings of the interviews conducted in phase one, 
by expert opinion obtained through a facilitated expert 
consensus process, and by a Cochrane systematic review. 
Phase three will begin once the guidelines have been 
developed. The researchers will again seek the opinions 
of healthcare professionals and methadone users in focus 
groups on how the guidelines should best be implemented. 
The research team is currently looking for interested 
professionals in the areas of primary care, drug or alcohol 
addiction treatment (in and outpatient), public health, 
psychiatry or hepatology to participate in the process. 
Interested professionals in general practice or general 
medicine, services users and community organisations are 
also very welcome to become involved.
For more information, or to join the multidisciplinary group 
developing clinical guidelines, please contact the researchers 
at 01 4730893 or by email: catherine-anne.fi eld@ucd.ie or 
jan.klimas@ucd.ie.
(Suzi Lyons)
1. See, for example, Kaner E et al. (2009) The effectiveness 
of brief alcohol interventions in primary care settings: 
a systematic review. Drug and Alcohol Review, 28(3): 
301–23.
Report highlights the beneﬁ ts of 
community-based drug projects 
Youth Work Ireland Cork (YWIC) published a report, 
Youthwork  as a response to drugs issues in the community,1 
in January 2011. The report was offi cially launched by Brian 
Crowley MEP in University College Cork. 
The research was commissioned by YWIC and was 
undertaken by Mr Pat Leahy, School of Applied Social 
Studies, UCC, and two students from the Bachelor of Social 
Work undergraduate degree course.
The report highlights the effectiveness of small, locally based 
harm reduction projects that feature dedicated and skilled 
workers in dealing with drug-related issues. The key fi ndings 
of the study, as published in the executive summary of the 
report (pp. 1–2), are reproduced below.
• A social rather than medical or legal based 
response to drugs issues offers policy makers and 
practitioners a genuinely holistic methodology for 
effective intervention.
• A local rather than universal response rooted in 
harm reduction allows for cultural, geographical 
and community factors to dictate the nature of 
an intervention.
• Effective praxis in this fi eld requires skilled, 
independent, refl exive, motivated and creative 
practitioners operating within a supportive 
agency setting.
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and Aoife Farrell, with Brian Crowley MEP and the Lord 
Mayor of Cork, Michael O’Connell
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• A clear theoretical framework encompassing 
knowledge of young people, drugs work, human 
behaviour and communities is a fundamental 
prerequisite to best practice.
• A high degree of service visibility in the community 
and easy access to the services is required.
• Community based projects work effectively with 
service users who will never enter treatment; 
they offer drug users an effective alternative to 
medicalised responses.
• In many cases inappropriate and problem drug use 
is a consequence of social inequality; interventions 
that can respond to these social issues in (particularly 
disadvantaged) communities offer the people who 
suffer from drugs issues a far more comprehensive 
range of services than a medicalised response. 
• Human contact between the service user and the 
practitioner in the form of a relationship founded on 
trust is the key building block of success.
• In terms of cost effectiveness community based 
projects offer excellent value for money; the 
overwhelming majority of funding is used in the 
provision of frontline services.
(Anne Marie Carew)
1. Leahy P, Bennet E and Farrell A (2011) Youthwork as a 
response to drugs issues in the community. A report on the 
Gurranabraher–Churchfi eld Drugs Outreach Project: profi le, 
evaluation, and future development. Cork: Youth Work 
Ireland Cork. www.drugsandalcohol.ie/14610
Report highlights the beneﬁ ts of community-based drug projects  (continued)
Update on blood-borne viral infections 
in injecting drug users
HIV surveillance in 2009
Voluntary linked testing for antibodies to HIV has been 
available in Ireland since 1985. According to the most recent 
report of the Health Protection Surveillance Centre (HPSC),1 
at the end of 2009 there were 5,369 diagnosed HIV cases 
in Ireland, of which 1,447 (27%) were probably infected 
through injecting drug use. 
Figure 1 presents the number of new cases of HIV among 
injecting drug users reported in Ireland, by year of diagnosis; 
data from 1982 to 1985 were excluded from the fi gure as 
these four years were combined in the source records. There 
was a fall in the number of HIV cases among injecting drug 
users between 1994 and 1998, with about 20 cases per year, 
compared to about 50 cases each year in the preceding 
years. There was a sharp increase in the number of cases in 
1999 (69 new cases), which continued into 2000 (83 new 
cases). Between 2001 and 2009 there was an overall decline 
in the number of new injector cases (38, 50, 49, 71, 66, 57, 
54, 36 and 30 respectively) when compared to 2000. It was 
diffi cult to interpret the trend owing to the relatively small 
numbers diagnosed each year, so a smoother curve (red plot 
line in Figure 1) was calculated using a rolling centred three-
year average. This curve presents a new baseline of between 
40 and 60 cases each year since 2006 and a declining trend. 
Of the 30 new HIV cases among injecting drug users 
reported to the HPSC in 2009, 24 were male and six were 
female, and the average age was 36 years (range 22–57). 
Nineteen of the 30 cases with a known address lived in 
Dublin, Kildare or Wicklow. 
Figure 1 Actual number and rolling average number of new cases of HIV among injecting drug users, by year of 
diagnosis, reported in Ireland, 1986–2009 
Source: Unpublished data reported to Department of Health and Children, National Disease Surveillance Centre 
and HPSC. 
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Table 1 Acute and chronic hepatitis B cases reported to the HPSC, by risk factor status, 2007–2009
Hepatitis B status
2007 2008 2009
Acute Chronic Unknown Acute Chronic Unknown Acute Chronic Unknown
n % n % n % n % n % n % n % n % n %
All cases
52 6.0 705 82.0 103 12.0 82 8.8 747 80.2 102 11.0 78 9.5 647 78.9 95 11.6
Cases with risk 
factor data 44 84.6 314 44.5 16 15.5 73 89.0 427 57.2 55 53.9 57 73.1 277 42.8 24 25.3
Of which:
Injecting 
drug users 1 2.3 5 1.6 1 6.3 0 0 6 1.4 1 1.8 1 1.8 9 3.2 0 0
Cases without 
risk factor data 8 15.4 391 55.5 87 84.5 9 11.0 320 42.8 47 46.1 21 26.9 370 57.2 71 74.7
Total 860 931 820
Source: Unpublished data from the HPSC 
Update on blood-borne viral infections in injecting drug users  (continued)
Hepatitis C surveillance in 2009
Hepatitis C is one the most common blood-borne viral 
infections among injecting drug users and is transmitted 
through contact with the blood of an infected person. The 
main routes of transmission are mother-to-baby, unsafe 
injections, transfusion of blood and blood products, and 
unsterile tattooing and skin piercing. There were 1,255 
cases of hepatitis C reported to the HPSC in 2009 (Table 2), 
compared to 1,527 cases in 2008. 
Table 2 Hepatitis C cases and notifi cation rates per 
100,000 population, 2004–2009
Year n Notifi cation rate 
2004 1126 26.6
2005 1409 33.2
2006 1217 28.7
2007 1552 36.6
2008 1527 36.0
2009 1255 29.6
Source: Unpublished data from the HPSC
An enhanced surveillance system for hepatitis C was 
introduced in Ireland in 2007. Enhanced surveillance is 
essential to identify risk factors and for planning prevention 
and treatment strategies. In 2009, 40% of newly reported 
hepatitis C cases had risk factor status reported (Table 3). 
As expected, the majority of these cases (70.9%) reported 
injecting drug use as the main risk factor. Four per cent of 
cases said that they had been recipients of blood or blood 
products at some time in the past and, according to the 
HPSC, were late reports to the system (N Murphy, HPSC, 
personal communication, 2009). 
In 2009, 83% of cases reporting injecting drug use as their 
main risk factor were notifi ed by services in Dublin, Kildare 
and Wicklow (Table 4). Seventy-three per cent were male 
and 62% were under 35 years old. 
Hepatitis B surveillance in 2009
Hepatitis B is a vaccine-preventable disease which is 
transmitted through contact with the blood or body fl uids 
of an infected person. The main routes of transmission are 
mother-to-baby, child-to-child, sexual contact and unsafe 
injections. The number of cases notifi ed to the HPSC 
increased in 2007 and 2008, but decreased by 12% in 2009, 
when it fell from 931 to 820. Of the 820 cases in 2009, 647 
had a chronic infection, 78 had an acute infection and the 
disease status of 95 cases was unknown. The surveillance 
system has recorded risk factor data since 2004. The 
percentage of cases notifi ed to the HPSC that included 
data on risk factors fell from 60% in 2008 to 44% (358 
cases) in 2009 (Table 1). Of these 358 cases, ten (2.8%) 
reported injecting drug use as their main risk factor. The 
number of cases who reported injecting drug use remained 
consistently low between 2005 and 2009, indicating the 
effectiveness of routine administration of the hepatitis B 
vaccine to such cases.
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Update on blood-borne viral infections in injecting drug users  (continued)
Table 3 Hepatitis C cases reported to the HPSC, by risk factor status, 2007–2009
2007 2008 2009
Risk factor status n % n % n %
Total number of cases 1552 1527 1255
Cases with reported risk factor data 662 42.7 575 37.7 506 40.3
  Of which:
  Injecting drug users 505 76.3 442 76.9 359  70.9
  Recipients of blood/blood products 31 4.7 23  4.0 20 4.0
  Other risk factors 90 13.6 78  13.6 80 15.8
  No known risk factor identifi ed 
  by patient or doctor 36 5.4 32  5.6 47 9.3
Cases without reported risk factor data 890 952 749
Source: Unpublished data from the HPSC
Table 4 Hepatitis C cases who reported injecting drug use as a risk factor, by age, gender and place of residence, 
2007–2009
2007 2008 2009
n % n % n %
Total number of known injector cases 505 442 359
Gender
Male 338 66.9 316 71.5 261 72.7
Female 166 32.9 124 28.1 96  26.7
Unknown 1 0.2 2 0.5 2 0.6
Age
Mean age 32.8 33.2 34.1
Median age 31 31.5 33
Under 25 years 48 9.5 45 10.2 35 9.7
25 to 34 years 284 56.2 231 52.3 189 52.6
Over 34 years 171 33.9 162 36.7 134  37.3
Age not known 2 0.4 4 0.9 1 0.3
Place of residence
Dublin, Kildare or Wicklow 448  88.7 377 85.3 299 83.3
Elsewhere in Ireland 57 11.3 65 14.7 60 16.7
Source: Unpublished data from the HPSC
(Jean Long)
1. Jackson S, O’Donnell K, Moran J and O’Hora A (2010) 
HIV & AIDS in Ireland 2009. Dublin: Health Protection 
Surveillance Centre. 
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Barriers to and facilitators of hepatitis C 
testing
Hepatitis C infection is common among injecting drug users 
(IDUs), yet access to hepatitis C care, particularly treatment, 
is suboptimal. There has been little in-depth study of IDUs’ 
experiences of what enables or prevents them engaging at 
every level of hepatitis C care, including testing, follow-up, 
management and treatment processes. 
A qualitative study aimed to explore these issues with current 
and former IDUs in the greater Dublin area.1 Between 
September 2007 and September 2008 in-depth interviews 
were conducted with 36 service users across a range of 
primary and secondary care services, including two addiction 
clinics, a general practice, a community drop-in centre, 
two hepatology clinics, and an infectious diseases clinic. 
Interviews were analysed using a grounded theory approach. 
Of the 36 participants interviewed, 28 were men and eight 
were women. They ranged in age from 24 to 54 years, with 
a median age of 32 years. The median reported age at fi rst 
injecting drugs was 18.5 years (range 14–29 years). Of the 
28 who reported their main problem drug, 79% reported 
heroin and 21% cocaine. Thirty-three (91%) participants 
reported testing positive for hepatitis C, of whom four (11%) 
reported HIV/HCV co-infection.
Among the factors infl uencing access to and uptake of HCV 
care were:
• perceptions that every injector had this invisible 
infection (hepatitis C) and that its effects were not as 
serious as those of HIV;
• perceptions that the investigations and treatments for 
hepatitis C were more severe than the infection itself; 
• use of coping strategies, such as blocking awareness, 
escape, support and positive thinking, to deal with 
fears about the future effects of hepatitis C, 
or anxieties about investigations or treatment;
• the quality of relationships with health care providers; 
• contact with services, encouraging and caring 
doctors and nurses, family ties, recovery from 
addiction, and convenient access to testing and 
treatment; and
• continued substance use, employment (lack of 
free time), contraindications to treatment, lack of 
reminders and lack of opportunity.
In conclusion, IDUs face multiple barriers to HCV care but a 
range of facilitators were identifi ed that could increase access 
to and uptake of treatment.
(Jean Long)
1. Swan D, Long J, Carr O, Flanagan J, Irish H, Keating S 
et al. (2010) Barriers to and facilitators of hepatitis C 
testing, management, and treatment among current and 
former injecting drug users: a qualitative exploration. 
AIDS Patient Care and STDS, 24(12): 753–762. 
www.drugsandalcohol.ie/14416
External review of methadone 
treatment protocol makes wide-ranging 
recommendations 
The results of the fi rst external review of the Irish methadone 
treatment protocol were published on 20 December 
2010.1 The HSE commissioned Michael Farrell, professor of 
addiction psychiatry at Kings College London, to conduct the 
review, assisted by Joe Barry, professor of population health 
medicine at Trinity College Dublin. This is the second review 
of the protocol; the Methadone Prescribing Implementation 
Committee carried out an internal review in 2005.2
The terms of reference for the external review were to review 
the methadone treatment protocol with regard to:
• maximizing provision of treatment, including 
detoxifi cation, stabilisation, and rehabilitation;
• clinical governance and audit;
• effectiveness of referral pathways;
• the enrolment and training of GPs, the criteria for 
Level 1 and Level 2 GPs, and the GP co-ordinator role;
• the appropriateness and effi cacy of urinalysis testing;
• data collection, collation and analysis; and
• engagement with the Department of Justice on the 
prescribing of methadone in Garda stations.
The review was informed by 69 written submissions and 
the conclusions of 38 oral hearings with stakeholders on 
the impact of the protocol. The main points of these inputs 
are outlined in chapter 5 and appendix 2 of the report. The 
authors state that the original protocol achieved its aims, 
especially in relation to improving both poor prescribing 
and the quality of independent practitioner practice. The 
current review covers a wide range of new issues, including: 
developing a model of service for rural Ireland, promoting 
better integration between and among services, the need to 
review benzodiazepine prescribing, changing the regime of 
urine testing and the need to deal urgently with methadone 
prescribing in Garda stations. 
The list of recommendations below, extracted in an abridged 
form from the published report, give an overview of the 
scope of the review. The full text of the recommendations is 
on pp. 33–36 of the report.
1. Maximising treatment provision and the effi cacy of 
referral pathways
1.1. Requests for detoxifi cation should have a defi ned time 
frame for response and should be reviewed as part of a 
service audit process.
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1.2. There should be a mechanism to rapidly access 
treatment for the six months after detoxifi cation to 
ensure support if relapse occurs.
1.3. The redrafting of the methadone regulations to 
incorporate buprenorphine (alone or with naloxone) 
treatment should be completed to ensure a broader 
range of treatment options. To this end, the title 
needs to be changed and could be “The Opioid 
Treatment Protocol”.
1.4. Services with a focus on key workers and 
multidisciplinary work should be promoted 
and developed.
1.5. An integrated services approach should account 
for family, community and user groups and it is 
recommended that these voices get a more prominent 
place in the future planning and development of 
drug services.
1.6. There is an urgent need for a service model outside 
of Dublin that has a clear focus on rural aspects of 
service delivery. 
1.7. In areas where the service currently relies on doctors 
travelling from Dublin, it is desirable that more 
permanent local medical input is organised in the near 
future for the purposes of continuity of service delivery.
1.8. The professional expertise of the adolescent services 
and the midwifery services should be used for 
developing an overall national strategy in these 
specifi c topics.
1.9. Implementation of a once-yearly brief instrument, 
such as the Treatment Outcome Profi le, would 
provide important information on the performance 
of individuals and on the overall performance of the 
service. There is need to create a sense of progression 
and promote movement within and between services.
1.10. Services should use the full range of skills of the 
multidisciplinary team to ensure that health and social 
problems of drug users is evenly addressed.
1.11. The treatment of Hepatitis C Virus among drug users 
needs to be expanded further.
1.12. There is a need to develop a more structured and 
explicit care planning process. Everyone should have 
a clearly documented care plan that is regularly 
reviewed and updated, drawn up within the fi rst three 
months of treatment.
1.13. The development of an electronic record of care 
planning is necessary if proper care planning is to be 
comprehensively implemented. 
2. Clinical governance and audit
2.1. It is desirable that there be some option for fl exibility 
around the appointment of HSE clinical directors and 
that the director has a background and training to the 
level recognised as an Addiction Specialist.
2.2. The lines of reporting and accountability for 
professionals in all of the services to be clarifi ed.
2.3. Audit should now be developed across the full range 
of drug services where standards around practice 
could be reviewed.
2.4. The audit process should also be used to monitor 
treatment drop-out.
2.5. The development of joint guidelines that would 
enable benchmarks to be set against which future 
audits could be measured. Such guidelines should be 
developed by a joint working group of the College 
of Psychiatry of Ireland and the ICGP with input from 
relevant other professional groups.
2.6. There is a need to link major expansion in delivery 
of drug treatment to prisoners with the community 
based services. 
2.7. The Pharmaceutical Society of Ireland demonstrated 
an interest in playing a part in improving the 
standards of prescribing of benzodiazepines. This 
work needs further development and should be 
undertaken as soon as possible in order to reduce poor 
benzodiazepine prescribing practice across all sectors 
of services in the HSE.
2.8. Recommendation 10 from the Report of the 
Benzodiazepine Prescribing Committee (2002)3 
should be implemented. 
3. Enrolment of GPs, training of GPs, the 
criteria for level 1 and level 2 GPs, and the GP 
Co-ordinator role
3.1. It should be an expectation that all trainees 
completing GP professional training have 
demonstrable competence to meet criteria for level 1.
3.2. There is a need to expand the number of level 2 
general practitioners.
3.3. There should be a stated time limit for patients to 
be with level 2 GPs and GP Co-ordinators should 
ensure that the patient moves on to a level 1 GP 
within 12 months. 
3.4. Level 2 GPs are requesting a change of the cap on 
numbers to be raised from 35 to 50. We recommend 
that this be done.
3.5. The cap on the number of patients with level 1 GPs 
should be abolished.
3.6. The roles of the GP Co-ordinators should be 
overhauled and the task of moving patients from level 
2 to level 1 GPs be prioritised, in conjunction with 
local management. 
3.7. The model of GP nurse liaison practitioners who work 
to both support and move patients on should be 
further developed. 
3.8. As new structures evolve the National GP Co-ordinator 
post should be reviewed.
4. Urinalysis testing, its appropriateness 
and effi cacy
4.1. Frequent urine testing should be stopped. 
4.2. The supervision of urine testing should be 
eliminated except where there is a legal requirement 
for supervision and that oral fl uid or temperature 
testing be used to indicate whether a fresh sample is 
being provided.
4.3. The technology behind oral fl uid testing has improved 
substantially and it is now possible to undertake on site 
saliva testing. 
4.4. The clinical guidelines jointly developed by the ICGP 
and the College of Psychiatry of Ireland should include 
an implementation plan for the move to less urine 
testing and a greater clinical focus on the use of the 
results of drug testing samples. 
4.5. Consideration should be given to piloting one or two 
contingency management treatment programmes to 
assess their viability.
External review of methadone treatment protocol  (continued)
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4.6. It would be desirable to introduce a mechanism for 
periodic monitoring of the levels of supervision of 
substitution treatment. 
5. Methadone prescribing in Garda stations
5.1. There is a need for a fundamental review of the 
procedures and systems for medical assessment of 
people in Garda custody.
5.2. There is a need for clear and explicit guidelines for the 
management of opioid dependence while in Garda 
custody. A working group with a relevant range of 
stakeholders should be urgently established. 
5.3. The overall health care input to Garda stations should 
be reviewed with consideration that operational 
responsibility and fi nancial aspects of this service be 
transferred to become a responsibility of the HSE.
5.4. The doctors attending Garda stations should be at a 
minimum level 2 trained GPs. 
5.5. Doctors attending users in Garda stations should have 
access out of hours to the CTL and should also be able 
to obtain information from Pharmacists on the last 
time of medication dispensing.
5.6. Garda stations should come under the protocol.
6. Data collection, collation and analysis
6.1. In developing a care planning approach, consideration 
should be given to the broader utility of this data 
monitoring with a view to some brief outcome 
monitoring process being built into this, where the 
status of an individual is systematically recorded on a 
once-yearly basis.
6.2. There should ideally be a systematic approach that 
enables wider data linkage through possible use of the 
PPS number that would enable ongoing mortality and 
other service utilisation analysis. Such work would help 
in tracking the pathways and careers of service users 
and provide valuable information on the long term 
outcomes of users.
6.3. There is a need for legislative change to allow the 
linkage of data from different data sources.
6.4. We recommend the establishment of a group 
comprising the main data controllers so that 
maximum use can be made of the data collected, in a 
secure and confi dential environment with appropriate 
privacy protection. 
7. Other
7.1. Handwriting exemption procedures should 
be introduced.
7.2. Nurse prescribing of controlled drugs should be 
explored and if possible developed further in line with 
international practice. 
7.3. There is a need for better linkage and for 
ensuring priority access of prisoners to community 
based treatment after release from prison from all 
Irish prisons.
(Suzi Lyons)
1. Farrell M and Barry J (2010) The introduction of the Opioid 
Treatment Protocol. Dublin: Health Service Executive. 
Available at www.drugsandalcohol.ie/14458
2. Methadone Prescribing Implementation Committee 
(2005) Review of the Methadone Treatment Protocol. 
Dublin: Department of Health and Children. Available at 
www.drugsandalcohol.ie/5962
3. Benzodiazepine Committee (2002) Report of the 
Benzodiazepine Committee. Dublin: Department of Health 
and Children. Available at www.drugsandalcohol.ie/5348 
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Treated opiate users: alcohol use and 
treatment outcomes 
Researchers analysed data from the Research Outcome Study 
in Ireland Evaluating drug treatment effectiveness (ROSIE) 
study to investigate alcohol use among opiate users and 
associated treatment outcomes.1 The aim of the research 
was to examine the frequency and quantity of alcohol use 
among opiate users at entry to treatment and at follow-up 
to establish ‘whether the success rate of a program may be, 
in part, related to the alcohol using habits of the client’.
ROSIE was the fi rst national, prospective longitudinal opiate 
drug treatment outcome study to be done in Ireland. The study 
recruited 404 new opiate drug-treatment clients in 2003/2004. 
These were followed up at one year (76% re-interviewed) and 
at three years (88% re-interviewed).2 The mean age of the 
participants was 27 years, and 72% were men. 
For the purposes of the study described here, data relating 
to 242 of the original ROSIE intake were classifi ed according 
to the participants’ alcohol usage. The three categories 
used were: abstainers (had not drunk in the past 90 days); 
medium drinkers (consumed up to 70g (men) or 50g 
(women) of alcohol per typical using day); and heavy 
drinkers (consumed more than 70g (men) or 50g (women) 
per typical using day). The analysis showed that at the 
start of the study 49% of men and 43% of women were 
defi ned as heavy drinkers. At the three-year follow-up, the 
proportion of heavy drinkers had dropped for both groups – 
to 26% of men and 28% of women. 
The association between alcohol use and crime, health, 
employment, personal fi nances, and drug usage was 
investigated. The study found that abstainers were the lowest 
offenders in terms of certain crimes, including assault. Logistic 
regression was used to investigate the link between drinking 
and drug usage at the three-year follow-up. It was found that 
abstainers used heroin and other drugs less frequently.
The authors state that their results show that the link 
between drug and alcohol use is complex, and that other 
factors, such as gender, age and ongoing or changing 
alcohol and drug usage, need to be considered when 
assessing and planning treatment for opiate users in order 
to target their treatment effectively.
(Suzi Lyons)
1. Stapleton R and Comiskey C (2010) Alcohol usage and 
associated treatment outcomes for opiate users entering 
treatment in Ireland. Drug and Alcohol Dependence, 107: 
56–61.
1. For more information and results from the original ROSIE 
study, see www.nuim.ie/rosie
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Legal update
This update covers drug-related Acts and Bills of the 
Oireachtas introduced or progressed during 2010 and up 
to the dissolution of the 30th Dáil (Parliament) in February 
2011. It also identifi es new substances brought under 
control within the terms of the misuse of drugs legislation. 
Acts to control new psychoactive substances
The National Drugs Strategy (interim) 2009–2016 (NDS) 
fl agged as an emerging issue the sale in Ireland of 
psychoactive substances that were not in breach of the 
existing law, commonly referred to as ‘legal highs’; these 
substances were generally being sold in ‘head shops’. 
Actions 14 and 15 in the NDS called for ongoing 
monitoring of the legislative framework.1 Subsequently, as 
head shops continued to multiply across the country at a 
rapid rate, the government gave priority to implementing 
these two actions.2 
The Misuse of Drugs Act 1977 (Controlled Drugs) 
(Declaration) Order 2010 made on 11 May 2010 
declared a range of legal highs to be controlled drugs. 
Three associated Statutory Instruments signed on the 
same day gave effect to the Order. Under this legislation, 
approximately 200 individual legal high substances, which 
had been on sale in head shops, and which included the vast 
majority of products of public health concern, were declared 
to be controlled drugs. They include broadly:
 ■ synthetic cannabinoids (contained in SPICE products); 
 ■ benzylpiperazine (BZP) and piperazine derivatives 
(commonly known as ‘party pills’); 
 ■ mephedrone, methylone, methedrone, butylone, 
fl ephedrone, MDPV (i.e. cathinones, often sold as baths 
salts or plant food); 
 ■ gamma butyrolactone (GBL) and 1,4 butanediol;
 ■ ketamine and tapentadol (substances that have 
legitimate medicinal use but which can be subject to 
misuse); and
 ■ certain narcotic and psychotropic substances that Ireland 
is obliged to bring under control in order to comply with 
UN conventions.
The Criminal Justice (Psychoactive Substances) Act 
2010 came into force in August 2010. This legislation 
was enacted to introduce more general control by way of 
criminal justice legislation to deal with head shop products 
as they emerged. The Act also gives appropriate powers to 
the gardaí and to the courts to intervene quickly, by way of 
prohibition notices and prohibition orders, to prevent the 
sale of psychoactive substances. 
The Act includes the following provisions:
Section 3 provides for the offences of selling, 
importing and exporting psychoactive substances for 
human consumption. Section 3 (1) provides for the offence 
of selling a psychoactive substance, knowing or being 
reckless as to whether it is being acquired or supplied for 
human consumption.
Section 4 creates the offence of selling an object, knowing 
that it will be used to cultivate by hydroponic means any 
plant. Hydroponic cultivation is the cultivation of plants 
in liquid containing nutrients, without soil, and under 
controlled conditions of light, temperature and humidity. 
This method of cultivation is known to be used for the 
purpose of growing cannabis indoors.
Section 5 provides for the offence of advertising a 
psychoactive substance or object to which Section 4 applies.
Section 7 provides that a Garda Superintendent (or higher) 
may serve a prohibition notice on a person where he or she 
believes that the person is selling, importing or exporting 
psychoactive substances for human consumption, selling 
objects for use in cultivating by hydroponic means any plant.
Section 20 provides that a person guilty of an offence under 
the Act is liable on summary conviction to a fi ne of up to 
€5,000 or imprisonment for up to 12 months or both, or on 
conviction on indictment to a fi ne or to imprisonment not 
exceeding 5 years or both.
Following the introduction of the Act, the Gardaí visited head 
shops in early September; only 19 were open and none were 
selling psychoactive substances (Garda Síochána, personal 
communication, 2010). A number of Bills proposed by 
opposition parties in the Dáil in 2010 in relation to the head 
shops issue are listed in the table overleaf.
Other new Acts applicable to drug offences
• The Criminal Justice (Money Laundering and 
Terrorist Financing) Act 2010 provides for offences 
of, and related to, money laundering in and outside 
the State; to give effect to Directive 2005/60/EC of 
the European Parliament and of the Council of 26 
October 2005 on the prevention of the use of the 
fi nancial system for the purpose of money laundering 
and terrorist fi nancing.
• The Criminal Procedure Act 2010 makes provision 
for a modifi cation of the rule against double jeopardy 
in order to allow a person who has been acquitted 
of an offence to be re-tried in circumstances where 
new and compelling evidence emerges or where the 
acquittal is tainted due, for example, to corruption 
or intimidation of witnesses or jurors or perjury. The 
rule against double jeopardy provides that no person 
may be put at risk of being punished twice for the 
same offence. The legislation applies to a number of 
drug-related offences.
• The Road Traffi c Act 2010 provides for a reduction 
in the blood alcohol content (BAC) limit for drivers 
and also provides powers to assist the Garda 
Síochána in forming an opinion as to whether a 
driver is under the infl uence of an intoxicant (drug or 
drugs) and to carry out a preliminary impairment test 
on such drivers.
• The Criminal Justice (Public Order) Act 2011 
prohibits harassment or intimidation of members of 
the public by persons who engage in begging and 
confers powers on members of the Garda Síochána 
to give directions to persons to desist from begging, 
in certain circumstances such as where they are 
begging near cash machines or in front of places 
of business. It also provides for a series of sanctions 
including fi nes and possible imprisonment for 
breaches of the law.
• The Communications (Retention of Data) Act 
2011 requires service providers, those engaged 
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in the provision of a publicly available electronic 
communication service or a public communication 
network by means of fi xed line or mobiles or the 
internet to retain data relating to fi xed and mobile 
telephony, for 1 year, and data relating to internet 
access, internet email and internet telephony for 2 
years, and provides for disclosure in relation to 
the investigation of specifi ed offences including 
Customs offences.
Status of Bills before the Dáil
Bills before the Dáil at that time of its dissolution on 1 
February 2011 are deemed to have lapsed. It is for the new 
government to decide whether they will be restored in the 
new Dáil. Current status of relevant Bills is shown in the 
table below.
Legal update  (continued)
Title and explanatory memorandum Status 
The Spent Convictions Bill 2007 (No 48 of 2007) is intended to apply where a prison sentence not 
exceeding six months or a fi ne or penalty have been imposed, and then only after a certain number of 
years have elapsed without a further conviction. The purpose of the Bill is to help rehabilitate convicted 
persons through facilitating their reintegration into the workforce and allowing them to build new careers. 
Publication 
expected 
during 
Summer 
Session 2011
The Criminal Justice (Forensic Evidence and DNA Database System) Bill 2010 (No 2 of 2010), 
among other things, replaces the existing statutory and common law arrangements governing the taking 
of samples for forensic testing from suspects for use as evidence in criminal investigations and proceedings 
with an updated statute-only regime, provides for the establishment of a DNA database system for use by 
the Garda Síochána as an intelligence source for criminal investigations, provides for the taking of samples 
for the purposes of the DNA Database System and other matters relating to the System, and implements 
the DNA-related elements of the Council Decision 2008/615/JHA of 23 June 2008 on the stepping up of 
cross-border co-operation, particularly in combating terrorism and cross-border crime.
Heads have 
been agreed 
and text is 
being drafted
The Planning and Development (Amendment) Bill 2010 (No 10 of 2010) provides that a change of use 
of a structure to use as a head shop or a sex shop shall not be exempted development, so as to ensure that 
such premises would have to obtain planning permission under the relevant planning legislation.
Publication 
expected 
late 2011
The Non-Medicinal Psychoactive Substances Bill 2010 (No 18 of 2010) establishes a new body known 
as the Non-Medicinal Psychoactive Substances Regulatory Authority. This Authority will regulate the sale, 
production, import, distribution and marketing of non-medicinal psychoactive substances and products that 
can have an effect on perception, health and wellbeing when consumed or otherwise used by persons.
Lapsed
The Proceeds of Crime (Amendment) Bill 2010 (No 30 of 2010) amends the Proceeds of Crime Act 1996. 
The purpose of the Bill is to reduce from 7 years to 2 years the waiting period before the Criminal Assets 
Bureau can apply to the High Court for the disposal and forfeiture of assets frozen under section 3 of the 
Proceeds of Crime Act 1996. 
Lapsed
(Johnny Connolly)
1. Department of Community, Rural and Gaeltacht Affairs 
(2009) National Drugs Strategy (interim) 2009–2016. 
Dublin: Department of Community, Rural and Gaeltacht 
Affairs. Actions 14 and 15.
2. Department of Health and Children (2010) Opening 
statement for meeting of Joint Committee on Health and 
Children in relation to recent legislation made to control 
certain substances under the Misuse of Drugs Act 1977. 
Press release issued 1 June 2010. Available at 
www.dohc.ie/press/releases/2010/10100601.html
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Council of Europe highlights drug-
related violence in Irish prisons
The availability of drugs, the existence of feuding gangs, and 
overcrowding have been identifi ed as factors contributing 
to ‘high rates of inter-prisoner violence in Mountjoy prison’, 
according to a report by the Council of Europe’s Committee 
for the prevention of torture and inhuman or degrading 
treatment or punishment (CPT).1 Although the CPT 
acknowledges a number of measures which have been taken 
to address safety concerns since its visit in 2006, Mountjoy 
Prison, it states, ‘remains unsafe for prisoners and prison 
staff alike. … Stabbings, slashings and assaults with various 
objects are an almost daily occurrence’ (p. 21). 
The CPT delegation observed that drug misuse remains 
a ‘major challenge’ in all prisons visited, and that 
‘management and health-care staff in most prisons visited 
acknowledged both the rising numbers of prisoners with a 
substance abuse problem and the widespread availability 
of drugs’ (p. 41).
The CPT acknowledges that, since its visit in October 2006, 
further investment has been made to implement the Irish 
Prison Service drug strategy through initiatives such as 
the provision of detoxifi cation, methadone maintenance, 
education programmes, addiction counselling and drug 
therapy programmes. However, the CPT states that it has 
‘serious concerns over the manner in which methadone 
prescribing is carried out in Cork, Midlands and Mountjoy 
Prisons’ (p. 41).
Methadone, according to the CPT, should only be prescribed 
as part of a comprehensive drug treatment programme that 
includes engagement with ‘addiction counsellors, addiction 
nurses and as required an addiction psychiatrist’ (p. 42). 
Furthermore, it states: ‘The dose of methadone prescribed as 
maintenance should be that required to stabilise a prisoner’s 
drug use to the extent that the inmate injects or uses opiates 
less frequently and remains in contact with prison addiction 
services’ (p. 42). These practices were not observed at either 
Midlands or Mountjoy prisons, where, according to the CPT, 
there were a number of serious shortcomings. Prisoners who 
were on a methadone prescription at the time of admission 
‘often merely had the dose continued and were not required 
to engage with the addictions counsellor … many of the 
methadone prescriptions were illegible … there was a lack of 
medical review of the prescription … there was no reference 
to the frequency of drug use, including injecting, or to the 
nature of illicit drugs consumed; for example, monitoring 
through regular analysis of urine’ (p. 42). At Midlands prison 
‘urinalysis results were not annotated in prisoners medical 
records; apparently, they were not even kept at the prison’ 
(p. 42).
A further concern related to the prescription of methadone 
as a detoxifi cation agent either upon admission to prison 
or when an inmate identifi ed him/herself as having an illicit 
drug use problem. The absence of any assessment as to 
whether a prisoner was likely to suffer from drug withdrawal 
subsequent to admission and the practice of placing a 
prisoner who gave a history of drug use on a three-week 
methadone detoxifi cation programme were also highlighted 
in the report. Given that there was no routine follow-up 
of withdrawal or other symptoms and no assessment as 
to whether prisoners were continuing their illicit drug use 
on top of the prescribed methadone detoxifi cation, the 
delegation concluded that ‘for a number of prisoners in 
receipt of a methadone detoxifi cation prescription it could 
be stated that this was simply “free petrol”’ (p. 42). 
The CPT also notes the additional measures taken to prevent 
drugs entering prisons, such as security checks on staff 
and visitors, the development of canine drug detection 
units, the introduction of mandatory drug testing, booked 
visits and improved intelligence gathering. It states that 
the effectiveness of these measures should be carefully 
monitored, suggesting for example, that ‘security checks on 
staff should be as rigorous as they are for visitors, which was 
not the case at Mountjoy Prison’ (p. 41).
The CPT concludes its report with a list of recommendations, 
comments and requests for information. Included among 
the drug-related recommendations are the following:
 ■ all prisoners admitted while on a methadone 
maintenance programme in the community to be able 
to continue such maintenance within prison as part of a 
comprehensive drug treatment programme;
 ■ prisoners undergoing drug withdrawal to be provided 
with the necessary support to alleviate their suffering and 
not to be placed in a cell without integral sanitation;
 ■ steps to be taken to remedy the defi ciencies related to 
the prescription of methadone.
In its published response to the CPT report,2 the Irish 
government explains that, while the information gathered 
by the CPT in relation to visits, reports and consultations 
of this nature is confi dential, ‘when requested to do so by 
the Government concerned, the Committee is required 
to simultaneously publish its report, together with the 
comments of the Government’ (p. 5). The government’s 
request to have both the CPT report and its own response 
published was made ‘in the interests of openness, 
transparency and accountability’. Consequently, the Council 
of Europe published on the same day the CPT report and the 
response of the Irish government to the report.
(Johnny Connolly) 
1. Council of Europe (2011) Report to the government of 
Ireland on the visit to Ireland carried out by the European 
Committee for the prevention of torture and inhuman or 
degrading treatment or punishment (CPT). Strasbourg: 
Council of Europe. www.cpt.coe.int
2. Council of Europe (2011) Response of the government 
of Ireland to the report of the European Committee for the 
prevention of torture and inhuman or degrading treatment 
or punishment (CPT) on its visit to Ireland. Strasbourg: 
Council of Europe. www.cpt.coe.int
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Best practice: What it is, what it isn’t
Cited from article by Marica Ferri in Drugnet Europe, No. 73, 
January–March 2011
‘Best practice is the best application of available evidence 
to current activities in the drugs fi eld.’ This is according to a 
group of experts tasked with developing a working defi nition 
of the concept when responding to drug use. ... According 
to the defi nition agreed, fi ve points should be considered 
before applying the term best practice to an intervention, 
namely:
• underlying evidence should be relevant to the 
problems and issues affecting those involved 
(professionals, policymakers, drug users, their 
families);
• methods should be transparent, reliable and 
transferable and all appropriate evidence should 
be considered in the classifi cation process;
• experience in implementation, adaptation and 
training should be systematically collected and 
made available;
• contextual factors should be studied by modelling 
different prevalence levels so as to assess the impact 
of an intervention on the population; and
• evidence of effectiveness and feasibility of 
implementation should both be considered for 
the broader decision-making process.
Highlighted in the discussions were the many factors to 
be taken into account when identifying and promoting 
best practice, such as how to export experiences to 
different contexts.
Measuring cannabis dependence in the general 
population
Cited from article by Danica Klempová in Drugnet Europe, 
No. 73, January–March 2011
The EMCDDA estimates that there are at least 4 million 
Europeans (1 % of all adults) using cannabis on a daily or 
almost daily basis. Most of these are males, reaching up to 
5–7 % of young men (15–34 years) in some countries.
Studies show that between a third and one half of daily 
cannabis users fulfi l dependence criteria. In order to 
formulate adequate policies and responses in this fi eld, a 
reliable and valid measure of cannabis dependence or abuse 
in the population is essential. The EMCDDA is currently 
collaborating with national experts1 to develop a common 
European measurement methodology, with results expected 
at the end of the year.
Pioneering work in this area began in 2002 in some 
countries2 where psychometric scales — short instruments 
to assess heavier patterns of drug use — were incorporated 
into population surveys and tested. Results of this work 
were reported regularly to the EMCDDA expert group on 
‘Prevalence and patterns of drug use among the general 
population’. In recent years, the EMCDDA has actively 
promoted and supported the translation, adaptation and 
validation of such scales in additional countries, in pursuit of 
a common European approach.
1. Czech Republic, Germany, Ireland, Spain, France, Italy, 
Hungary, the Netherlands.
2. Germany, France, the Netherlands, Poland — 
see Drugnet Europe No. 63 and No. 67.
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In the last four years 35,000 people have been killed in 
Mexico as drug gangs fi ght to gain control of the cocaine 
and marijuana traffi c into the United States. Mexico is not 
alone. Other Latin American and Caribbean countries are 
also experiencing high levels of delinquency, violence, 
and corruption fuelled by illegal drugs; in some countries, 
democratic stability is threatened. 
This issue of In brief reports on the work of three groups of 
citizens from Latin American countries, and also the US, Europe 
and Pakistan, who have come together to look for solutions. 
These citizens include former politicians and public servants, 
business and commercial leaders, representatives from the NGO 
sector, and writers and public intellectuals.
While Latin America is the major global exporter of cocaine and 
cannabis, the main markets for these drugs are in the US and 
Europe. These citizen groups are calling for an open and far-
reaching public debate on how regions of the world can work 
together to design and implement policies that reduce both the 
supply and the demand for illicit drugs, rather than focusing 
just on the problems arising within their own jurisdictions. 
In 2009 the Latin American Commission on Drugs and 
Democracy, convened by former presidents of Brazil, 
Colombia and Mexico, published a 41-page report Drugs & 
democracy: toward a paradigm shift. The authors point out 
that prohibition, comprising (1) eradicating production, (2) 
disrupting drug fl ows and (3) criminalising consumption, 
has not yielded the expected results. While the EU’s policy of 
focusing on the reduction of the damages caused by drugs as a 
matter of public health has proved ‘more humane and effi cient’, 
the authors suggest that by not emphasising the reduction of 
domestic consumption, the EU has failed to curb the demand 
for illicit drugs that stimulates their production and exportation 
from other parts of the world. 
The Latin American Commission proposes a new paradigm 
based on the following three principles.
1. Treat drug users as a matter of public health – changing 
their status from ‘drug buyers’ in the illegal market to 
that of patients cared for in the public health system should 
help to undermine the economic foundations of the illegal 
drugs trade.
2. Reduce drug consumption – through developing 
information, education and prevention campaigns that 
can be understood and accepted by young people, who 
account for the largest contingent of users. The authors 
point to the success of information and prevention 
campaigns to reduce tobacco consumption, which were 
based on clear language and arguments consistent with the 
experience of those being targeted. 
3. Focus repression on organised crime – target the most 
harmful effects of organised crime on society, and combine 
eradication efforts with properly fi nanced alternative 
development programs adapted to local realities in terms of 
viable products and conditions for their competitive access 
to markets. www.drogasedemocracia.org/English/ 
In February 2011 the Inter-American Dialogue, supported 
by the UK-based Beckley Foundation, released a 24-page 
report Rethinking US drug policy. Endorsing the work of the 
Latin American Commission, this report asserts that, on the 
supply side, the damage caused by the production and trade in 
illegal drugs, combined with the increasingly well-documented 
collateral damage from anti-drug efforts, has now extended 
throughout the Americas. On the demand side, the authors 
comment that no existing policy option offers a solution to the 
problem of drug consumption. According to the authors, many 
advocates of harm reduction admit that while harm reduction 
may diminish the damage that drugs and anti-drugs measures 
do to individuals and their families, to communities and nations, 
such interventions may also lead to higher rates of consumption.
The authors argue that because the US exerts such an 
enormous infl uence on global drug policy worldwide, changes 
in US laws and policies could profoundly affect the approaches 
of other governments and multilateral institutions. They call for 
the following actions.
1. Support recent Congressional initiatives to establish House 
and Senate commissions to review US anti-drug strategies 
and develop alternative approaches.
2. Join with other nations to organise an inter-governmental 
task force on narcotics strategy that would review and 
appraise global drug policies. 
3. Revise outdated UN treaties that underpin the international 
narcotics regime. 
4. Expand data collection, analysis, and research on multiple 
aspects of drug problems and the policies and programs 
designed to address them.
5. Identify and scale up successful drug programs that 
promise to reduce drug addiction and the health risks 
to addicts, increase the prospects of rehabilitation, and 
decrease drug-related crime. www.thedialogue.org / 
www.beckleyfoundation.org 
In January 2011 the Global Commission on Drug Policy was 
established, including representatives from Latin America, the 
US, Europe and Pakistan. Building on the work of the Latin 
American Commission, its goals are to review the assumptions, 
effectiveness and consequences of the ‘war on drugs’ approach, 
evaluate the risks and benefi ts of different national responses 
to the drug problem, and develop actionable, evidence-based 
recommendations for constructive legal and drug policy reform. 
Six background papers have been prepared 
covering the Commission’s main areas of inquiry and 
substantive engagement:
1. The current international drug control regime. 
2. A global overview of drug policies and laws. 
3. The production and supply chain.
4. Criminal justice challenges. 
5. Demand reduction, including prevention, harm reduction 
and treatment.
6. Drug trade and organised crime, and the economic and 
political impacts of these activities.
Chaired by ex-Brazilian president Fernando Henrique Cardoso, 
with George Schulz, former US Secretary of State, as Honorary 
Chair, the Commission includes the former presidents of Mexico 
and Colombia, Ernesto Zedillo and Cesar Gaviria; ex-EU foreign 
affairs chief Javier Solana; former Norwegian minister and 
international negotiator, Thorvald Stoltenberg; former President 
of Switzerland and Minister of Home Affairs, Ruth Dreifuss; 
former Secretary-General of the International Chamber of 
Commerce, Switzerland, Maria Cattaui; former State Secretary 
at the German Federal Ministry of Health, Germany, Marion 
Caspers-Merk; Greek prime minister, George Papandreou; 
former Chairman of the US Federal Reserve, Paul Volcker; 
human rights activist and former UN Special Rapporteur on 
Arbitrary, Extrajudicial and Summary Executions, Pakistan, Asma 
Jahangir; executive director of the Global Fund to Fight AIDS, 
Tuberculosis and Malaria, Michel Kazatchkine; John Whitehead, 
banker, civil servant and chair of the World Trade Center 
Memorial; Virgin chief Richard Branson; and writers Carlos 
Fuentes and Mario Vargas Llosa. 
www.globalcommissionondrugs.org 
(Compiled by Brigid Pike)
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Recent publications
On our shelves
Books recently acquired by the National Documentation 
Centre on Drug Use
High society: mind-altering drugs in history and culture
Mike Jay
Thames & Hudson (2010); ISBN 978-0-500-25172-0
Voluntary action and illegal drugs: health and society in 
Britain since the 1960s
Alex Mold and Virginia Berridge 
Palgrave Macmillan (2010); ISBN: 978-0-230-52140-7
www.drugsandalcohol.ie/14368
Journal articles
The following abstracts are cited from recently published 
articles relating to the drugs situation 
in Ireland.
Plant food for thought: a qualitative study of 
mephedrone use in Ireland
Van Hout MC and Brennan R 
Drugs: education, prevention and policy 2011; Early online: 1–11
www.drugsandalcohol.ie/14541
Mephedrone is currently under legislative control in Ireland. 
Research on this drug remains scant, and is primarily 
UK based. This exploratory research aimed to present 
a ‘consumptive snapshot’ of this emerging drug in the 
Irish drug scene, with specifi c focus on mephedrone-user 
experiences, social situatedness of use and risk discourses. 
Twenty-two in-depth interviews were undertaken with 
young Irish people aged 18–35 years, who had used 
mephedrone in the six months prior to fi eldwork. Analysis 
of the resulting narratives identifi ed unique mephedrone-
user decision-making processes, particular drug effects 
and outcomes, socially contextualized mephedrone use 
and harm-reducing strategies grounded in prior illicit 
and polydrug taking careers. The research supports UK-
based fi ndings, which suggested the presence of drug 
displacement patterns between licit and illicit, with Irish 
mephedrone user preferences centralised in mephedrone 
availability, competitive pricing and general lack of quality 
illicit stimulants in the street trade. Policy makers and drug 
educational specialists are dealing with rapid metamorphoses 
and re-branding of cathinone derivatives circumventing 
legislation amid widespread internet availability.
Experiences with mephedrone pre-and-post legislative 
controls: perceptions of safety and sources of supply 
McElrath K and O’Neill C 
International Journal of Drug Policy 2011; 22(2):120–127 
www.drugsandalcohol.ie/14625
In April 2010, mephedrone and related cathinone derivatives 
were banned under the UK’s Misuse of Drugs Act 1971. 
The purpose of this paper was (1) to explore respondents’ 
experiences with mephedrone, (2) to examine users’ 
perceptions about the safety of mephedrone, and (3) to 
examine sources of mephedrone supply during the pre- and 
post-ban periods.
Semi-structured interviews were conducted with 23 
adults who had used mephedrone during 2009-2010. 
Most respondents reported positive experiences with 
mephedrone; none reported that its once-legal status 
implied that it was safe to use. Very few reported buying 
mephedrone online or from head shops during the pre-
ban period; most obtained it from friends or dealers, and 
mephedrone was widely available during the 10-week period 
following the ban. 
The fi ndings are discussed in the context of what appears to 
be a rapidly changing mephedrone market. We discuss the 
possible implications of criminalising mephedrone, including 
the potential displacement effects and the development of 
an illicit market.
Keltoi rehabilitation programme: Post-discharge 
outcome study
White E, Browne C, McKiernan B and Sweeney B 
Drugs: education, prevention and policy 2011; Early online; 1–8
www.drugsandalcohol.ie/14766
This article presents the results of a survey of clients of Keltoi, 
a residential rehabilitation facility for former opiate-dependent 
individuals. The survey was carried out to evaluate the success 
of its unique programme in assisting participants to pursue 
a drug-free life. Between 1 and 3 years post-discharge, 
53.7% (n = 80) of all former Keltoi clients were interviewed 
with respect to abstinence, health, crime and employment 
measures. This was an uncontrolled cohort study.
Abstinence from all illicit drugs and alcohol in 30 days pre-
interview was reported by 51.3% (n = 41) of the cohort; 
60.0% (n = 48) reported abstinence from all illicit drugs 
excluding alcohol. Only 5.4% (n = 5) reported injecting 
behaviour. Outcomes are presented with respect to crime, 
health and risk behaviours, social and personal functioning 
and employment.
The percentage of those reporting abstinence from illicit 
drugs was high at 60.0%, and was associated with minimal 
criminal activity and higher positive outcomes than non-
abstinence. Exploring the association between the Keltoi 
approach and these encouraging results has implications 
for the design, delivery and evaluation of drug treatment 
services in Ireland, particularly in the context of the 
treatment and rehabilitation pillar of the National Drugs 
Strategy 2009–2016.
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Insula and drug cravings
Garavan H 
Brain Structure and Function 2010; 214(5–6):593–601
This paper reviews the role of the insula in drug craving. 
Evidence is presented that drug craving may be a particular 
instance of the anterior insula’s broader role in interoception 
and subjective feeling states similar, for example, to thirst 
and hunger. An important role for the insula in craving is 
supported by evidence of insular activity changing with 
satiety and with the top-down cognitive modulation of 
cravings. Cognitive processes involving the insula’s role in 
awareness of one’s own behaviour may also contribute to 
craving insofar as the avoidance of craving might require 
subjective awareness of the endogenous and exogenous 
cues that initiate it. Finally, some consideration is given to 
sex differences and developmental processes in craving.
Treating alcohol-related problems within the Irish 
healthcare system, 1986–2007: an embedded disease 
model of treatment? 
Cullen B 
Drugs: education, prevention and policy 2011; Early online: 1–10
www.drugsandalcohol.ie/14769
This article assesses the implementation of the policy on 
the treatment of alcohol problems in Ireland during the 
period 1986–2007. At the commencement of this period, 
a major policy statement in relation to the treatment of 
alcohol within the mental health care system presaged 
radical change – in effect it proposed a shift from the then 
dominant disease model of alcoholism to one that was 
focused on public health principles. Towards the end of 
the period, a further statement made the rather sanguine 
claim that many of the intended changes had taken 
place. This article adopts a more critical approach. Using 
epidemiological data from annual reports on the activities 
of mental health centres and also drawing from a recently 
conducted action-research project that focused on addiction 
treatment within a regional health authority, the article 
highlights that change has been slow and that some of the 
main tenets of the disease model remain in place.
Methadone and perinatal outcomes: a retrospective 
cohort study 
Cleary B, Donnelly J, Strawbridge J, Gallagher P, Fahey T, 
White M and Murphy D 
American Journal of Obstetrics & Gynacology 2011; 204(2): 
139.e1–9
www.drugsandalcohol.ie/14818
This study examined the relationship between methadone 
maintenance treatment, perinatal outcomes, and neonatal 
abstinence syndrome. This was a retrospective cohort 
study of 61,030 singleton births at a large Dublin maternity 
hospital from 2000 to 2007.
There were 618 (1%) women on methadone at delivery. 
Methadone-exposed women were more likely to be 
younger, to book late for antenatal care, and to be smokers. 
Methadone exposure was associated with an increased risk 
of very preterm birth (less than 32 weeks gestation), being 
small for gestational age (below 10th percentile), admission 
to the neonatal unit, and diagnosis of a major congenital 
anomaly. There was a dose-response relationship between 
methadone and neonatal abstinence syndrome. 
The researchers conclude that methadone exposure is 
associated with an increased risk of adverse perinatal 
outcomes, even when known adverse sociodemographic 
factors have been accounted for. They call for dedicated, 
well-resourced, multidisciplinary care for these women and 
their neonates to improve perinatal and long-term outcomes.
Recent publications  (continued)
(Compiled by Joan Moore – jmoore@hrb.ie)
May 
10 May 2011
Drugs, alcohol and young people 
Venue: Easter Road Stadium, Edinburgh 
Organised by / Contact: The Big Issue 
Email: susan.reid@bigissue.com
www.bigissue.com
Information: The following topics will be discussed at 
this conference:
 ■ Why does alcohol affect young people differently 
from adults? 
 ■ Why are some of our young people being marginalised 
and excluded and how can we prevent it from 
happening? 
 ■ Would we need recovery and harm reduction if drug 
policy was reformed? 
 ■ How can I cope with the fall-out from the 
spending review? 
 ■ Where can I ask the questions that matter to me? 
 ■ What have Twitter and Facebook got to do with me? 
12–13 May 2011
The public health agenda: making patient-centred care the 
imperative
Venue: Harrogate International Centre, North Yorkshire
Organised by / Contact: Royal College of General 
Practitioners / Healthcare Events
Email: matt@healthcare-events.co.uk
www.healthcare-events.co.uk/conf/booking.
php?action=home&id=570
Information: This is the RCGP’s 16th national conference 
on working with drug and alcohol users in primary care, 
attracting over 500 GPs, shared care workers, specialists 
and commissioners. In planning the conference, we are 
conscious of the challenges and opportunities facing primary 
care and our services under the coalition government; we 
welcome the move to place drugs and alcohol services 
within the public health arena, but are keen to ensure that 
the changes ahead do not diminish patient centred, user 
led treatment. The theme of the 2011 Conference addresses 
Upcoming events
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Upcoming events  (continued)
the relationship and tensions between these 
two areas: the imperative to maintain patient 
focused care as substance misuse is recognised 
as a public health issue.
17 May 2011
Recovery Scotland 2011
Venue: Glasgow Science Centre 
Organised by / Contact: Pavilion, Association 
of Directors of Social Work (ADSW) 
http://pavilion-live.co.uk/
recoveryscotland/2011/02/16/home
Information: Three years on since publication of 
the Scottish Government’s The Road to Recovery 
drugs strategy, Recovery Scotland 2011 provides 
a timely overview of the current recovery 
landscape in Scotland today. 
The conference will identify and explore 
best practice, key issues and opportunities 
for innovation amid funding cuts. It will also 
examine the reconfi guration of services and 
an increasing awareness of the important role 
of service users in facilitating and sustaining 
the recovery journey. It will focus fi rstly on the 
personal and social recovery journey – identity, 
social networks and community involvement, 
recovery champions, recovery capital and also 
on the ongoing recovery journey in relation to 
employability, families, housing and offending.
19–21 May 2011 
8th UK/European symposium on addictive 
disorders
Venue: Grange City Hotel, London EC3N 2BQ 
Organised by / Contact: UKESAD 
http://www.ukesad.org
Information: The UK’s largest Addiction 
Recovery event, the UK/European Symposium 
on Addictive Disorders (UKESAD), will include 
over 60 international experts in the fi eld of 
addiction who will share their knowledge with 
attendees in approximately 40 presentations. 
UKESAD is the only event in the UK and Europe 
which has demonstrated how to achieve long-
term, sustainable recovery. 
June
1 June 2011
The role of treatment in recovery: a one-day 
national conference
Venue: Thistle Hotel Glasgow, Glasgow, G2 3HN 
Organised by / Contact: Scottish Training on 
Drugs and Alcohol (STRADA) Alcohol (STRADA), 
Email: Debbi.Limond@glasgow.ac.uk 
www.drugmisuse.isdscotland.org/news/
conference_01062011.pdf
Information: This national conference 
developed by STRADA, a partnership of the 
University of Glasgow and DrugScope, will 
provide an unrivalled opportunity to update 
knowledge, hear about good practice and to 
meet others working in the same area. There 
is much discussion on the role treatment plays 
in recovery; while its value in the initiation 
and maintenance stages of recovery is 
acknowledged, there are debates about how 
treatment services should work with peer 
support, mutual aid and universal services to 
bring about long term recovery for individuals, 
their families and communities.
29 June 2011
Innovations in drug and alcohol recovery 
Venue: Majestic Hotel, Harrogate, 
North Yorkshire 
Organised by / Contact: Cygnet Health Care 
Email: karentopping@cygnethealth.co.uk
www.cygnethealth.co.uk/about-us/events
Information: Offering tangible, practical 
information and experiences that delegates can 
take back to the workplace, this national event 
opens a forum for sharing and the exploration of 
new ideas in the fi eld of drug & alcohol recovery.
November
3–4 November 2011
National Drugs Conference 2011
Venue: Radisson Blu Royal Hotel, Dublin 8 
Organised by / Contact: Irish Needle Exchange 
Forum (INEF)
Email: info@inef.ie
http://inef.ie
Information: Details will be posted on the INEF 
website in due course.
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